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ABSTRACT
MOLECULAR CANDIDATES FOR BLOCKING THE TRANSMISSION OF VECTORBORNE DISEASES
Ashish Naresh Vora
Old Dominion University, 2018
Director: Dr. Hameeda Sultana

Vector-borne diseases (VBDs) require urgent attention as they have a high
mortality rate, with 700,000 people dying in a year as of 2017. So far, extremely few
reliable vaccination strategies and solutions have emerged. Transmission blocking
vaccines are one among many solutions available to manage the control of VBDs.
These require identification of both vector and pathogen molecules that play important
roles in the transmission, dissemination and establishment of VBDs. Our strategy is to
characterize these candidates that play important roles in vector-host-pathogen
interactions. This manuscript presents two such studies identifying the participation of
two arthropod molecules in vector-host-pathogen interactions. The first study uses
quantitative and standard PCR to detect dengue serotypes DENV2/3 RNA and
immunoblotting to detect viral proteins within mosquito extracellular vesicles (EVs). The
EVs carry infectious viral RNA and are able to establish infection in naïve, recipient cells
of various lineages. Mosquito EVs mediate DENV2 transmission through a newly
identified mosquito exosome marker, designated as Tsp29Fb, an orthologue of human
CD63. Silencing Tsp29Fb reduced DENV2 load, it’s interaction with DENV2 E-protein
and transmission of DENV2 through EVs.
Our second study identifies another arthropod molecule in ticks. The tick HSP70like molecule is involved in disrupting the host coagulation pathway through the
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induction of fibrinogenolysis. Immunoblotting analysis revealed reduced D-Dimer, a
fibrin degradation product, in ticks fed on immunocompromised hosts. In addition, ticks
fed on immunocompromised hosts exhibit a lower expression of the arthropod HSP70like molecule that correlated with higher engorgement weights. This differential activity
is linked to the immune states and/or background of the vertebrate host, in this case
mice. Inhibition of the tick HSP70-like molecule in the salivary gland lysates of fed ticks
abrogates its fibrinogenolytic activity. These studies together identify two strong
candidates playing different roles for blocking the transmission of VBDs from two
different arthropods.
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OVERVIEW

Vector-borne diseases (VBDs) caused over 1.1 million deaths in 2002 and
700,000 deaths in 2017 that comprise of 17% of all infectious diseases (WHO 2004,
2017). Out of the 700,000 deaths in 2017, 400,000 were due to malaria, which remains
the leading VBD today (WHO 2017). Other major VBDs include Leishmaniasis,
Trypanosomiasis, Yellow fever, Dengue, Chagas disease and Japanese encephalitis
fever, in descending order of their mortality rates (WHO 2004, 2017.) There are over 19
million species of arthropods, some of which carry or are known to carry and transmit
deadly diseases to humans (Ødegaard, 2000). The leading arthropod vectors of disease
are mosquitoes and ticks (Conway et al., 2014; Neelakanta and Sultana, 2015) and can
be used as models for studying VBDs.
So far, the VBD management strategies have involved direct treatment of
disease, blocking acquisition and transmission of pathogens and finally vector
population control (Conway et al., 2014). Out of these the most successful strategy we
have today is vector control which involves the use of physical barriers, pesticides,
repellents, and attractants (Conway et al., 2014; Foster and Hancock, 1994; Kato et al.,
2008). There is also a sterile insect technique involving the release of transgenic insects
with dominant lethality to reduce vector population (Harris et al., 2012). Direct treatment
of viral infections has not been very successful due to a lack of available antiviral
treatment options and the therapy involves just palliative care (Katzelnick et al., 2017a,
2017b; Whitehorn and Simmons, 2011). Blocking acquisition involves either the
identification of arthropod molecules important for viral pathogenesis or use of biological
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agents like Wolbachia that play a role in suppressing viral replication (Cheng et al.,
2010; Glaser and Meola, 2010; Mousson et al., 2012; Perera-Lecoin et al., 2013).
However, a major problem with these strategies is that it cannot prevent a primary
infection from the pathogen.
This leaves transmission blocking strategies as the new promising avenue for
investigation. The blocking of transmission would also require the identification of
molecular players that facilitate the transmission of pathogen or those that suppress the
host’s immune system (Conway et al., 2014; Neelakanta and Sultana, 2015; Zhou et al.,
2018). The candidates considered as targets for blocking transmission have to match
certain criteria to be of high quality. These criteria outline that the target should be
indispensable for vector-pathogen interaction and silencing of the target should lead to
a direct reduction in pathogen load, dissemination and pathogenesis. The primary
amino acid sequence of the candidate should be highly conserved among the
population of the vector species. It should be able to generate a high antibody titer and
be compatible with multiple adjuvants. Finally, the target molecule should not generate
an exaggerated immune response leading to immunological disorders in the host
(Neelakanta and Sultana, 2015).
The best place to look for these molecular players lies at the host-vectorpathogen interface i.e. at the bite site of an infected vector. Many studies have been
performed to determine the absolute importance of vector-attachment and host-seeking
behavior of the vectors in order for them to secure a blood meal (Brossard and Wikel,
2004; Francischetti et al., 2009; Hovius et al., 2008; Ribeiro and Francischetti, 2003;
Ribeiro et al., 2007; Wikel, 2013), without which there would not be any physical

3
channel to transmit the pathogen. Several other studies have been performed to show
that vector saliva enhanced the chance of establishing and increased the severity of
infection, only some of which are cited here (Ader et al., 2004; Jones et al., 1989;
Kročová et al., 2003; Labuda et al., 1993; Le Coupanec et al., 2013; Schneider et al.,
2004; Styer et al., 2011; Surasombatpattana et al., 2014). These molecules are of
myriad classes and have multiple functions which include behaviors like antihemostasis, anti-inflammation, immunosuppression, anti-coagulation, vasodilation etc.
(Calvo et al., 2010; Neelakanta and Sultana, 2015; Ribeiro et al., 2007). Hence, this
vector-pathogen-host interface provides an ideal area for the search of molecular
candidates for blocking transmission of VBDs.
With this in mind, this manuscript highlights two studies that show evidence
fulfilling the first requirement of a molecular candidate to block transmission of VBDs.
The first study published in 2018, focuses on how a newly identified tetraspanin domain
containing glycoprotein mediates the transmission of dengue virus through mosquito
extracellular vesicles. The second study published in 2017 focuses on the role of a tick
HSP70 and the differential feeding response elicited by ticks upon feeding on hosts with
different immune backgrounds.
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MOSQUITO EXTRACELLULAR VESICLES MEDIATE DENGUE VIRUS
TRANSMISSION THROUGH INTERACTION WITH A TETRASPANIN
GLYCOPROTEIN TSP29FB

INTRODUCTION

Dengue is a major VBD, which according to the 2017 WHO report puts 3.9 billion
people at risk of infection (Brady et al., 2012). There are 96 million reported cases of
dengue with observable symptoms worldwide every year with actual number of
infections estimated to be over 300 million (Bhatt et al., 2013). A subset of these
infections, around 500,000 are severe infections with symptoms of hemorrhage and
multiple organ failure leading to 19,000 deaths every year (Yacoub et al., 2013).
Attempts at developing and distributing vaccines for dengue has been challenging,
compounded by four serotypes (DENV1-4) and the antibody dependent enhancement
of the disease (Halstead and O’Rourke, 1977; Katzelnick et al., 2017a). The only
approved vaccine, Dengvaxia for dengue is not broadly protective and has been pulled
off the market (Hadinegoro et al., 2015). So far there are no drugs available for
treatment and management of the disease is limited to vector control and supportive
care (Conway et al., 2014).
The life cycle of dengue virus is like most other flaviviruses. Figure 1 shows the
standard model for dengue virus entry into the cells (Cruz-Oliviera et al., 2015). There is
a direct interaction of mature viruses with host cell receptors which then leads to
receptor mediated endocytosis (Cruz-Oliveira et al., 2015; Perera-Lecoin et al., 2013;
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Vega-Almeida et al., 2013). During the late endosomal stage, the low-pH triggers a
conformational change in the viral envelope (E)-protein, which fuses with the endosomal
membrane. Thus, releasing the genomic content of the virus directly into the cytosol
(Cruz-Oliveira et al., 2015; Rodenhuis-Zybert et al., 2010). Once inside, the positive
sense RNA genome gets translated to produce the RNA-dependent RNA polymerase
encoded by the viral RNA. This polymerase is then further able to replicate the viral
genome leading to translation of more viral proteins. Eventually the viral proteins are
assembled and the immature virus is passed through the trans-Golgi network (CruzOliveira et al., 2015; Rodenhuis-Zybert et al., 2010). At this stage there is cleavage of
furin on the virus that leads to its maturation and subsequent release through budding
off from the membrane (Cruz-Oliveira et al., 2015; Rodenhuis-Zybert et al., 2010). The
dengue genome is ~11kb long and consists of three structural proteins (M, C and E)
and seven non-structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5).
Out of these, multiple studies have reported the involvement of the dengue NS1 protein
in the contribution to viral toxicosis through suppression of the interferon response and
increasing viral toxicity (Guzman et al., 2010; Halstead, 2015).
Exosomes or small extracellular vesicles (EVs) have been shown to carry a
range of molecules including protein, RNA and even DNA (Colombo et al., 2014;
Gonzales et al., 2009; Théry et al., 2002; Villarroya-Beltri et al., 2014). Figure 2 shows
multi-vesicular endosomes (MVEs) containing intra-luminal vesicles that are released in
the extra cellular space when the endosomes fuse with the plasma membrane
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Figure 1. Life Cycle of Dengue Virus. Beginning on the top-left the image shows the receptor mediated
endocytosis of a mature dengue virus. The virus once taken inside the cell is present in the endosome
which when progresses to the late endosomal stage becomes acidic in pH. The acidic pH triggers the
fusion of the viral envelop with the endosomal membrane making the virus release its contents into the
cytoplasm. The RNA genetic material of dengue virus begins replicating and simultaneously gets
translated to produce the viral proteins. The viral RNA and proteins pass through the trans-Golgi network
to produce a mature dengue virus particle which is released into the extra-cellular space through
exocytosis. This image is reproduced from a paper on the dengue virus life cycle (Rodenhuis-Zybert et
al., 2010).

(Colombo et al., 2014; Théry et al., 2002). The small 30-150 nm sized EVs are
known as exosomes. Bigger sized EVs with sizes ranging from 150-1000 nm diameters
are known to directly bud off from the plasma membrane and are classified as
microvesicles (Colombo et al., 2014; Théry et al., 2002). Some studies have shown the
presence of virus components in mammalian exosomes (Arakelyan et al., 2017;
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Ramakrishnaiah et al., 2013). Previously published work from Dr. Sultana laboratory
was the first to characterize the role of arthropod EVs in pathogen transmission (Zhou et
al., 2018). This formed the basis of our hypothesis that dengue, which is a positive
single-stranded RNA virus could also be transmitted through EVs.

Figure 2. Biogenesis of Extracellular Vesicles. Exosomes (30-150 nm) are formed through
invaginations in the early endosome, giving rise to small vesicles called intraluminal vesicles. As these
endosome progress to the late endosomal stage known as multivesicular bodies, they contain
intraluminal vesicles loaded with various molecules. The multivesicular body through exocytotic
mechanisms fuses with the plasma membrane to release these vesicles in the extracellular space which
are then known as exosomes. Larger EVs (> 150 nm) can pinch of directly from the plasma membrane
and are classified as microvesicles. This image is adapted from a paper published on the recent
advancements on the use of exosomes as drug delivery vehicles (Bunggulawa et al., 2018).

This study shows for the first time, the presence of the full-length DENV2 RNA
genome and viral proteins in mosquito cell derived EVs and that these EVs are able to
establish an infection in naïve recipient cells from different lineages. These findings
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provide important data for the current and future avenues in understanding biology of
arthropod EVs in pathogen transmission which is a rapidly expanding field (Alenquer
and Amorim, 2015; Barile and Vassalli, 2017; Hackenberg and Kotsyfakis, 2018;
Madison and Okeoma, 2015; Schorey et al., 2015). To determine whether there are any
molecules that can be used to block transmission of disease through EVs, this study
investigated two molecules that are enriched in EVs, HSP70 and the mosquito
orthologue of human CD63 (LAMP3), Tsp29Fb. The results of which indicate that
Tsp29Fb plays an important role in transmission of DENV2 though EVs. The human
CD63 has also been implicated in the entry and exit of the human immunodeficiency
virus (HIV) (Li et al., 2014). Collectively, this study is not only critical in understanding
the molecular basis of the modes of flaviviral transmission from the arthropod vector,
but may also potentially lead to the development of better strategies to interfere with the
life cycle of this and perhaps other medically important vectors.
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RESULTS

Mosquito Cell-Derived EVs Contain DENV2 RNA and Proteins
Figure 3 shows increasing dengue load with time in Aedes albopictus mosquito
cell line (C6/36). Figure 3A shows a significant increase in the dengue burden in C6/36
cells, Figure 3B in C6/36 EVs and Figure 3C in Aedes aegypti mosquitoes (in vivo).
Since the viral load (both in cell line and in vivo) was high at 72 hpi (hours postinfection), we selected this time point for the isolation of EVs from mosquito cells. Figure
4A and 4B show the two different ultracentrifugation techniques used for the isolation of
EVs from in vitro cultures. Cryo-electron microscopy (cryo- EM) data generated in
collaboration with colleagues Drs. Woodsone and Sherman at UTMB were performed
on C6/36 EVs showed the presence of 30– 250 nm diameter EVs (Figure 5A), which
bear resemblance to EVs isolated from mammalian cells as described in literature
(Tauro et al., 2012; Théry et al., 2002). Figure 5B shows the detection of A. albopictus
HSP70 in each of the infected or uninfected EV fractions 2-6, with the highest level in
fraction 4 (Figure 5B). HSP70 was not detected in fraction 1 from EVs isolated from
uninfected or DENV2-infected groups (Figure 5B) indicating the absence of EVs (since
HSP70 is an EV marker). Figure 5B also shows increased presence of HSP70 in
infected EVs in comparison to uninfected fractions. DENV2 E-protein was higher in
infected EV fraction 5 in comparison to the other fractions (Figure 5B). Immunoblotting
also revealed both DENV2- glycosylated (Figure 5B, upper band) and endogenous
(lower band) E-protein in fraction 5 and 6. E-protein was not detected in uninfected
controls. The Ponceau S-stained images showed total protein profile in each fraction.
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Further quantitative real-time PCR (qRT-PCR) showed DENV2 total capsid transcripts
in EVs derived from infected C6/36 cells (Figure 5C). The same result was derived for
DENV3 capsid RNA in EVs derived from DENV3 infected A. albopictus cells. This
suggests that EVs may act as mediators of all serotypes of DENVs (Figure 5D). DENV2
E and nonstructural 1 (NS1) proteins were also detected in C6/36 cell lysates and EVs
(Figure 5E). E-protein level was higher in EVs in comparison with cell lysates at 72 hpi,
whereas no difference was observed with NS1 protein levels in either EVs or total cell
lysates (Figure 5E). Similar pattern of E-protein levels are seen in DENV3-infected
C6/36 cell-derived EVs and total cell lysates (Figure 5F). Coomassie-stained gel images
show the total protein profiles in both DENV2 and DENV3 groups (Figure 5E and 5F).
Quantification of A. albopictus EVs showed the highest prevalence of EV sizes were
between 50 and 100 nm in both uninfected and DENV2-infected groups (Figure 6A and
6B). Figure 6A and 6B also show that DENV2-infected cell-derived EVs had a higher
percentage of EVs in the size range 0-50 nm and fewer 100–150 nm sized EVs in
comparison to the uninfected EVs. This suggests that DENV2 may stimulate production
of smaller EVs. Figure 6C shows the counts of total number of EVs from uninfected or
DENV2-infected A. albopictus cells obtained from cryo-EM images collected from at
least three independent isolations. The counts did have a significant difference. For
biochemical quantification of EVs, we determined their total protein amounts using the
Bradford protein assay (BCA). Extracellular vesicles isolated from various number of
cells show a linear increase for EV proteins (Figure 6D and 6E). There was a negligible
difference in the EV protein amounts from infected or uninfected samples. These data
correlate with data in Figure 6A, 6B and 6C. DG-EV isolation performed determined
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whether EVs contain viral particles and the size of EVs that contain the viral particles.
An independent DG-EV isolation by filtering the culture supernatants with 0.22-μM filters
that yielded 12 fractions showed similar results (Figure 6F). To determine if A.
albopictus cell-derived EVs contain the full-length DENV2 genome, Mr. Wenshuo Zhou
(graduate student with Dr. Neelakanta) with support from Dr. Neelakanta performed a
PCR analysis (with oligonucleotides producing overlapping amplicons covering entire
DENV2 sequence) was performed (Figure 7A). The result shows the presence of the
full-length DENV2 genome in C6/36 cell-derived EVs. Fragments 1–10 amplified
products of 1,102 bp, 1,110 bp, 1,124 bp, 1,114 bp, 1,118 bp, 1,141 bp, 1,104 bp, 1,135
bp, 1,110 bp, and 1,048 bp. Fragment 11 (3′ end of the genome) amplified multiple
products, including the expected size of 717 bp. This may be due to the looped nature
of the 3′ end of the genome.

DENV2 RNA and Proteins are Securely Contained Inside the EVs
To eliminate the possibility of DENV2 viruses being present outside of the EVs,
we performed cryo-EM analysis on 6 C6/36 cell-derived DG-EV fractions (Figure 7B).
The infected EV fractions did not show any virions either inside or outside of these EVs.
These data suggest that viral RNA and proteins are perhaps sufficient for the infection
of naïve recipient cells. To determine if the viral RNA is bound to the EV exterior and
are thus delivered to the recipient cells, we treated our infected cell derived EVs and
viral stocks with RNase A (Figure 8A, 8B). DENV2 loads were determined from cells
exposed to RNase treated and untreated EVs. We obtained similar results with no
difference in the viral load in the C6/36 cells upon incubation with EVs or laboratory viral
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stocks prepared from DENV2-infected RNaseA-treated or untreated groups. To confirm
that the viral proteins too are contained inside the mosquito cell-derived EVs, and are
not on the exterior as contaminants, we designed and performed an E-protein 4G2antibody bead binding assay. There were no differences in viral loads between infected
EV fractions treated with either 4G2 antibody (that binds to viral E-protein) or with the
isotype control or the untreated controls (Figure 8C). We also tested the DENV2
laboratory stock as a control that showed reduced DENV2 loads in the recipient C6/36
cells in comparison with the isotype antibody-treated or untreated controls (Figure 8D).
In addition, we performed native-PAGE followed by immunoblotting with 4G2 antibody
on infected A. albopictus EVs treated with 0.1% Triton X-100 for 30 min at room
temperature, or treated with multiple freeze-thaw cycles or untreated samples. A higher
level of E-protein (in native state at ∼200–250 kDa) was detected in Triton X-100–

treated EV fractions in comparison with the levels in untreated or freeze-thawed

fraction. Ponceau S-stained images showed the total protein profile and served as
control. Immunofluorescence analysis with 4G2 antibody showed that EVs treated/lysed
with 0.1% of Triton X-100 had a higher fluorescent signal for DENV2 E-protein in
comparison with untreated EV fractions (Figure 8F). Enzyme linked immunosorbent
assay (ELISA) with 4G2 (an anti-E-protein antibody) further supported the native- PAGE
and immunofluorescence analyses, where higher loads of DENV2 E-protein were
detected when EVs were permeabilized with 0.1% of Triton X-100 in comparison with
untreated controls (Figure 8G). Taken together all of these data suggest that DENV2
RNA and proteins contained inside the A. albopictus EVs are not present as
contaminants on the outside.
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DENV2 Infectious RNA and Proteins are Transmitted to Mosquito, Murine, and
Human Cells through A. albopictus EVs
To determine if DENV2 RNA and proteins contained in A. albopictus cell-derived
EVs are viable and infectious to arthropod/ vertebrate host cells, we used EVs and EVdepleted supernatants (EDS; generated during EV pelleting and before PBS wash)
(Figure 4B). Immunofluorescence assays performed on naïve C6/36 cells treated with
infectious EVs showed a greater fluorescent signal for E-protein in comparison to EDStreated cells (Figure 9A). Higher concentrations of EVs showed similar results (Figure
9A). Infectious A. albopictus EVs and EDS were also tested in plaque assays (Figure
9B). A. albopictus cell-derived infectious EV pellet fractions yielded plaques at dilutions
of 1:10 that were too numerous to count, and around 25–30 plaques at a dilution of
1:100, and fewer than 5 plaques in dilutions of 1:1000. EDS treatment of A. albopictus
cells yielded no plaques. Further, we analyzed whether EVs derived from infected A.
albopictus are capable of transmitting DENV2 to other cell types. The result in Figure
9C shows a successful transmission and reinfection ability of A. albopictus EVs to naïve
mosquito C6/36 cells, mouse Mo-DCs, HaCaT cells, and HUVEC cells. No viral loads
were detected in any tested cell lines incubated with EDS (Figure 9C). The infection of
DENV2 in several other cell lines was assessed using dengue stock, which showed
detectable a load at 72 hpi (Figure 10B–10E). Infected A. albopictus cell derived EVs
were introduced to naïve cells used in Figure 10C-10E. Overall, these results suggest
that DENV2 viral RNA and proteins exit mosquito cells via EVs, and that these
infectious EVs mediate transmission of DENVs to human cells.
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Role of A. albopictus HSP70 in EV-mediated DENV2 Transmission
The qRT-PCR data in this section was contributed by Mr. Wenshuo Zhou, for the
published manuscript (Vora et al., 2018). Figure 5 and 6 demonstrate that the A.
albopictus HSP70 is present in EVs derived from mosquito cells. To determine if the A.
albopictus HSP70 plays a role in the EVs mediate transmission dengue, we
investigated the role of two isoforms of hsp70 (GenBank accession nos. JN132154 and
XM_019672019). Quantitative RT-PCR revealed that both hsp70 isoforms were
upregulated in C6/36 cells upon infection at 48 h and 72 hpi in comparison with 24 hpi
and uninfected controls (Figure 11A, 11B). The hsp70 transcript (GenBank accession
no. JN132154) was undetectable in EVs. The presence of hsp70 transcript GenBank
accession no. XM_019672019 was evident in EVs, without a significant change in
expression between uninfected and infected EVs (Figure 11C). Immunoblotting showed
an increased expression of HSP70 in EVs isolated from infected cells at 24 hpi in
comparison to 48 and 72 hpi and uninfected samples (Figure 11D). No change in
expression of HSP70 was observed between uninfected or infected C6/36 cell lysates
(Figure 11D). Coomassie-stained gel images show the total protein profiles in EVs and
total cell lysates. In addition, we tested the effect of inhibiting HSP70 on DENV2
transmission through EVs. QRT-PCR showed that C6/36 cells treated with VER-155008
(HSP70 inhibitor), followed by infection with DENV2 had significantly reduced
expression of hsp70 (XM_019672019, in comparison to the mock- (DMSO) treated
group (Figure 11E). No change was observed in XM_019672019 transcript expression
in EVs derived from these inhibitor-treated and DENV2-infected C6/36 cells (Figure
11E). Treatment with VER-155008 inhibitor did not decrease DENV2 load in either total
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cell or EV lysates (Figure 11F). The effects of VER-155008 inhibitor-treated infectious
EVs and EDS from the same batch were tested on naïve C6/36 cells. No difference was
observed in DENV2 loads in the inhibitor-treated group compared to the mock (Figure
11G). Similar results were obtained for EDS treated cells. As expected, DENV2 loads in
EV fractions showed significant differences compared with the EDS fractions. All these
data indicate that the up-regulation of A. albopictus HSP70 as an arthropod stress
response during DENV2 infection, but inhibition of this critical chaperone does not lead
to the reduction in viral burden or transmission.

Identification of a Mosquito EV Marker Tsp29Fb, a Tetraspanin Domaincontaining Glycoprotein
The human CD63 or LAMP-3 proteins are well-established markers for EVs/
exosomes (Colombo et al., 2014; Gonzales et al., 2009; Théry et al., 2002; VillarroyaBeltri et al., 2014). Hence, we decided to investigate the mosquito ortholog of human
CD63 as a marker of and mediator for the transmission of DENV2 through EVs. Using a
human CD63 primary amino acid sequence, (GenBank accession no. AHI151903) as a
query in the VectorBase, we identified tetraspanin domain-containing mosquito
orthologs in both A. aegypti (AAEL012532-RA) and A. albopictus (AALF020630- RA)
and designated these orthologs as Tsp29Fb. ClustalW alignment of an A. aegypti
Tsp29Fb amino acid sequence (Figure 12A) revealed 89% identity with A. albopictus
Tsp29Fb and 51% identity with Drosophila melanogaster tetraspanin 29Fb protein
(GenBank accession no. AAF90138). Aedes aegypti Tsp29Fb showed 28% and 27%
identity with human and mouse CD63 (GenBank accession no. CAJ18387),
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respectively. A phylogenetic analysis revealed that A. aegypti Tsp29Fb lies within the
same clade as A. albopictus Tsp29Fb and D. melanogaster tetraspanin 29Fb. The
human and mouse CD63s form a different clade (Figure 12B). Domain analysis of the
A. aegypti Tsp29Fb sequence revealed the presence of the tetraspanin domain (amino
acids 15–238), four transmembrane regions (amino acids 19–41, 56–78, 90–112, 211–
233), four myristoylation sites (amino acids 37–47, 76–82, 92–98, 228–234), and two
glycosylation sites (amino acids 125–129, 168–172) (Figure 12C). The identification of
an ortholog of the EV/ exosome marker CD63 named Tsp29Fb in the mosquito genome
suggests the presence of a putative EV marker in mosquitoes.

DENV2 Infection Up-regulates Tsp29Fb Expression in Mosquito EVs and Cells
To explore the function of Tsp29Fb in EV mediated transmission of DENV2 in
mosquitoes, we analyzed its expression in DENV2- infected A. aegypti mosquitoes (in
vivo) (Figure 13A). The results show very significant up regulation of tsp29Fb
(accession no. AAEL012532-RA) at 24, 48, and 72 hpi, in comparison to uninfected
mosquitoes. Similar expression patterns were observed in Aag-2 cells, derived from A.
aegypti mosquitoes. Quantitative RT-PCR analysis showed that in both Aag-2 EVs and
in cells, tsp29Fb was up-regulated upon infection at 48 and 72 hpi compared to
uninfected samples (Figure 13B, 13C). Quantitative RT-PCR also revealed significantly
higher transcripts of tsp29Fb (accession no. AALF020630-RA) at 24 and 48 hpi in
C6/36 cell-derived EVs (Figure 12D), and at 48 and 72 hpi in whole-cell lysates (Figure
12E). Time and MOI dependent expression of Tsp29Fb was also analyzed using
immunoblotting (Figure 13F and 13B). The results determined that for C6/36 cell-
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derived EV fractions and whole-cell lysates at different time points of 24, 48, and 72 hpi,
had higher Tsp29Fb protein expression in infected lysates in comparison to uninfected
samples (Figure 11F). This correlated with the qPCR data in Figure 13D and 13E.
Tsp29Fb expression is also upregulated with increasing infectious dose of DENV2
(Figure 13G). Total protein profiles in all four panels served as loading controls (Figure
13F and 13G). These data show that Tsp29Fb is upregulated both in vivo and in vitro
upon DENV2 infection.

Tsp29Fb Directly Interacts with DENV2 Envelope Protein
For further characterization of Tsp29Fb’s function in facilitating DENV2 infection
and transmission, we tested if it directly interacts with DENV2 E-protein.
Immunoprecipitations (IPs) performed with a human CD63 antibody and DENV2infected EVs and whole-cell lysates (suspended in modified RIPA protein lysis buffer;
150 μg as input in each group) showed the presence of DENV2 E-protein by
immunoblotting with 4G2, an anti- E-protein antibody (Figure 13H). The direct
interaction of Tsp29Fb to DENV2 E-protein was increased in cell lysates in comparison
to EV lysates. This could be due to a higher total amount of Tsp29Fb protein in cell
lysates than in EVs. An E-protein signal was not detected in uninfected controls. Figure
13I shows an IP of Tsp29Fb using PBS suspended intact arthropod EVs (freshly
isolated) using human CD63 antibody followed by immunoblotting with 4G2 antibody.
This too detected the precipitation of DENV2 E-protein in both mosquito cell-derived EV
fractions and whole cell lysates (we used 500 μg as input in each group for IP with PBS
suspended EV fractions). Coomassie blue-stained gel images showing total protein
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profile of input lysates used for IP served as controls. We also show that Tsp29Fb
neither interacts nor co-precipitates with actin in either EVs or total cell lysates (Figure
14B). These data served as a negative control for the direct interaction of Tsp29Fb with
DENV2 E-protein (Figure 13H and 13I). Actin protein immunoblots from both cells and
EVs lysates (resuspended in RIPA buffer) that were used as input for the IP assay
serve as a control (Figure 14C). These data suggest the presence of actin in input
lysates that neither interact nor co-precipitate with Tsp29Fb. Immunofluorescence
performed on A. albopictus cells showed co-localization of Tsp29Fb (Figure 14A) with
DENV2 E-protein in infected cells. Uninfected C6/36 cells and nuclei-stained (DAPI)
images served as controls. Altogether, these data indicate a role for mosquito EV
marker Tsp29Fb in facilitating infection and transmission of dengue virus through direct
interaction with the viral E-protein.

Inhibition of Tsp29Fb Reduces DENV2 Infection
We investigated the effect of inhibiting Tsp29Fb function to study its effect on
dengue replication and transmission through EVs. We generated the dsRNA against the
tsp29fb gene and sequenced it (Figure 15A and 15B) Transfection with tsp29fb dsRNA
resulted in lower tsp29Fb transcripts (Figure 16A) in Aag-2 cells and EVs. DENV2 load
in the same samples was significantly reduced (Figure 16B). Immunoblotting showed
the same result, with reduced E-protein and Tsp29Fb protein expression in both EVs
and total cell lysates compared to mock (Figure 16C). Total protein profiles shown by
Coomassie-stained gel served as loading controls. Blocking Tsp29Fb using the human
CD63 antibody in mosquito cells resulted in a reduced dengue load in EVs, cells at the
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transcriptional and translational level (Figure 16D-16F). Total protein profiles shown by
Coomassie-stained gels served as controls (Figure 16F). Significant differences with
CD63 antibody treatments and silencing suggest that inhibition of Tsp29Fb reduces
DENV2 load in cells that ultimately inhibits transmission of viral RNA and proteins via
EVs.

GW4869 Inhibitor Reduces DENV2 load, Transmission and Tsp29Fb Interaction
with DENV2 E-protein
Treatment of C6/36 cells with GW4869 an EV/ exosome release inhibitor
followed by DENV2 infection showed reduction in the DENV2 capsid transcript in EVs,
compared with the DMSO control (Figure 16G). Similar results were obtained with
immunoblotting analysis with anti- E-protein antibody at 18 and 24 hpi, in both infected
C6/36 cell-derived EVs and cell lysates in comparison with the DMSO controls (Figure
16H). Longer incubation duration with the inhibitor resulted in further reduction of Eprotein expression at 24 hpi in comparison to 18 hpi. Total protein profiles shown by
Coomassie-stained gels served as control. Infection of naïve C6/36 cells with EVs
derived from GW4869 inhibitor treated, infected mosquito cells showed reduced DENV2
viral RNA in the recipient cells in comparison with the DMSO control (Figure 16I). A
transwell assay was performed with C6/36 cells on top and HUVEC cells at the bottom.
The C6/36 cells were infected with DENV2 stock, EVs or EVs in addition to GW4869
(Figure 16J). The dengue load was determined in the HUVEC cells 48 hpi and shown to
be reduced in the inhibitor treated samples. The exosome inhibitor was also shown to
reduce the direct interaction of Tsp29Fb with the dengue E-protein through an IP
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performed with CD63 antibody and lysates from infected C6/36 cells. DMSO treated
samples were used as control (Figure 16K). These data indicate that the reduction in
EV release reduces dengue load and that the direct interaction of Tsp29Fb with Eprotein is not only required for DENV2 infection and pathogenesis in the arthropod host,
but also is essential for transmission of infectious EVs to the human host.
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Figure 3. DENV2 Infection Kinetics in C6/36 Cells, EVs and Mosquitoes.
(A and B) QRT-PCR analysis showing viral loads in DENV2-infected (5 MOI) C6/36 cells (n = 4) or in EVs
(n = 6) derived from DENV2-infected C6/36 cells Uninfected C6/36 cells or cell-derived EVs were used as
controls.
(C) QRT-PCR analysis showing DENV2 load in A. aegypti mosquitoes (n = 4). (Note: The data in panel C
was contributed by Mr. Wenshuo Zhou towards the publication of this data in Vora et al., 2018) DENV2
capsid mRNA levels were normalized to mosquito actin level. The value of p determined by Student’s
two-tailed t test is shown.
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Figure 4. Schematic Representation of the Methods Used for EV Isolation from Mosquito Cells.
(A) Schematic representation of OptiPrep TM (DG-EVs-iso) using density gradients of iodixanol.
(B) A regular ultracentrifugation technique used for EV isolation.
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Figure 5. EVs Derived from Mosquito Cells Contain DENV2/DENV3 RNA and Proteins.
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Figure 5. Continued.
(A) Cryo-EM images showing EVs isolated from uninfected or DENV2-infected (MOI 5, 72 hpi) C6/36
cells. Scale bar, 100 nm. (Note: The cryo-EM images were contributed by Drs. Woodson and Sherman at
UTMB).
(B) Immunoblotting from DG-EV-iso preparation showing enhanced DENV2 E-protein level and HSP70 in
fractions 4–6. EVs derived from uninfected cells serve as control. Total protein profiles from both groups
shown for comparison. Fraction number and calculated iodixanol density (g/mL) shown for reference.
(C and D) QRT-PCR analysis showing DENV2 or DENV3 load in EVs isolated from C6/36 cells at 72 hpi
(n = 5). DENV2/ DENV3 capsid mRNA levels were normalized to mosquito actin levels. The p value
determined by Student’s two-tail t test shown.
(E) Immunoblotting showing detection of DENV2 E-protein and NS1 in EVs and total lysates from whole
cells prepared from uninfected (UI) or infected (I) C6/36 cells at 72 hpi (MOI 5).
(F) DENV3-specific E-protein in EVs and total cell lysates from uninfected (UI) or infected (I) C6/36 cells
at 72 hpi (MOI 5) is shown. Protein sizes are indicated as kilo Daltons. Images showing total protein
profiles serve as loading controls in both (E) and (F).
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Figure 6. Estimation and Quantification of C6/36 EVs upon DENV2 Infection.
(A and B) Heterogeneous size distribution of EVs isolated from uninfected or DENV2-infected C6/36 cells
is shown. Y-axis represent number and X-axis indicate size range (e.g. 0-50 nm, in diameter) of EVs in
each group. The total number of EVs considered from different cryo-EM images is indicated as ‘n’.
Percentages were calculated based on the total number of EVs in each size range.
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(C) EVs numbers were counted from uninfected and DENV2-infected (MOI 5, 72 hpi) groups. The Y-axis
represents EVs number. ‘n’ indicates total number of images used in this quantification. Data shown in (AC) was generated by Mr. Wenshuo Zhou.
(D) and E) Quantification of arthropod EVs by measurement of total protein amounts (BCA method) from
uninfected or DENV2-infected (MOI 5, 72 hpi) EVs isolated from increasing density of 104, 105,106, 107
and 108 cells is shown from respective groups. Total EV protein concentration (measured as μg/μl) is
plotted against increasing cell number/density.
(F) Detection of DENV2 E-protein and EVs marker HSP70 in EVs derived as twelve fractions during
independent DG-EV isolation. Immunoblotting analysis from iodixanol density gradient EVs preparations
filtered through 0.22 μm showing enhanced DENV2 E-protein levels in fractions 9-12 from infected (MOI
5; 72 hpi) C6/36 cells. HSP70 was detected in all fractions and serve as EV marker. Total protein profile
from each fraction is shown for comparison. Fraction number and calculated iodixanol density (g/mL) is
shown on top for reference.
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Figure 7. EVs Derived from C6/36 Cells Contained DENV2 Full Length Genome and No Viral
Particles.
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Figure 7. Continued.
(A) Agarose gel images showing amplification of overlapping fragments from full-length genome in
arthropod EVs derived from DENV2-infected (5 MOI, 48 hpi) C6/36 cells. The cDNA derived from total
RNA was used as template. PCR generated 11 fragments (fragment sizes are shown in methods) show
the full-length DENV2 genome amplification. UI and I indicate uninfected and infected groups
respectively. NTC indicates no template control. M indicates DNA marker.
(B) Cryo-EM images showing EVs isolated from DENV2-infected (MOI 5; 72 hpi) C6/36 cells. EVs
isolated by density gradient (DG-EVs-iso) fractions are shown. Fractions are labeled from 1-6. Scale bar
indicates 100 nm in all six fractions. Panel (A) PCR was performed by Mr. Wenshuo Zhou and Panel B
images generated by Drs. Woodson and Sherman.
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Figure 8. DENV2 RNA and Proteins Are Securely Contained Inside EVs.
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Figure 8. Continued.
(A) QRT-PCR analysis showing DENV2 loads in naïve C6/36 cells (incubated with EVs derived from
independent batch of DENV2 infected (MOI 5; 72 hpi) C6/36 cells treated with RNase A). Uninfected
treated samples serve as control (n = 4).
(B) QRT-PCR analysis showing DENV2 loads in naïve C6/36 cells infected via either infectious EVs
derived from DENV2-infected (MOI 5, 72 hpi) C6/36 cells from an independent batch or DENV2
laboratory viral stocks with known virus titer (MOI 5) and treated with RNase A. The untreated samples
serve as control (n = 6).
(C) QRT-PCR analysis showing viral load in EVs samples isolated from C6/36 DENV2-infected cells (MOI
5; 72 hpi) that were treated with 4G2 or isotype matched control antibodies. Untreated EVs samples
served as control (n = 6). ‘ns’ indicates not significant in (B) and (C). DENV2 capsid mRNA levels were
normalized to mosquito actin levels in (A, B and C).
(D) QRT-PCR analysis showing viral loads in DENV2 laboratory viral stocks (MOI 5) that were treated
with 4G2 or isotype matched control antibodies. Untreated group was used as control (n = 6). DENV2
levels were normalized to total RNA in (D) as actin is not detectable.
(E) Native-PAGE followed by immunoblotting analysis showing presence of E-protein from DENV2infected (MOI 5; 72 hpi) C6/36 cell-derived EVs (I) treated with Triton-X-100 (0.1%), or freeze-thaw cycles
or untreated samples held on ice. Ponceau S stained blot image showing total protein profiles serve as
loading control. EVs isolated from uninfected cells (UI) were used as controls.
(F) Relative fluorescence measurements from EVs (derived from DENV2-infected C6/36 cells at 72 hpi)
treated with 0.1% Triton X-100 is shown. Untreated group was used as control (n = 6).
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(G) ELISA showing increased detection of E-protein from EVs isolated from C6/36 DENV2-infected cells
(MOI 5; 72 hpi) upon treatment with 0.1% Triton X-100 in comparison to untreated control (n = 4). The p
value was determined by Student’s two-tail t test is shown.
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Figure 9. EVs Derived from Mosquito Cells Are Infectious and Transmit DENV2 to Both Arthropod
and Mammalian Cells.
(A) Fluorescent microscopic images showing detection of E-protein in C6/36 cells infected via EVs
derived from independent batch of DENV2-infected (MOI 5; 72 hpi) C6/36 cells. EDS-treated cells serve
as control (n = 5) (Scale bar, 200 μm.).
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(B) Quantitative assessment of number of plaques on Vero cells treated with EVs (in different dilutions) or
EDS fractions (as similar dilution) derived from DENV2-infected (MOI 5, 72 hpi) C6/36 cells are shown.
TNTC indicates “too numerous to count” (n = 2).
(C) QRT-PCR analysis showing viral loads at 72 hpi in naïve C6/36 or mouse dendritic or human HaCaT
or HUVEC cells treated with EVs or EDS fractions derived from DENV2- infected (MOI 5, 72 hpi) C6/36
cells are shown (n = 3 for each cell line). ND indicates not detectable. Depending on the cells that were
used, DENV2 capsid mRNA levels were normalized to mosquito, mouse, or human actin levels.
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Figure 10. Re-Infection of Mosquito Cells via Infectious EVs and Infection Kinetics of DENV2 in
Various Mammalian Cell Lines.
(A) Fluorescent microscopic images showing detection of E-protein in C6/36 cells infected with EVs
diluted 10-fold that corresponds to 12.6 μg of total EVs protein as estimated by the BCA, derived from
independent batch of DENV2-infected (MOI 5; 72 hpi) C6/36 cells. The C6/36 cells treated with EVsdepleted supernatant (EDS) fractions serve as control (n = 5). Scale bar indicates 200 μm in each image.
(B, C, D and E) QRT-PCR analysis showing viral loads in DENV2-infected Vero cells at indicated time
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points (of 48, 72 and 96 hpi), mouse-derived dendritic cells at 72 hpi, human HaCaT cells at 72 hpi, and
human HUVEC cells at 72 hpi. Cells were infected with laboratory virus stocks (MOI 5). Uninfected cells
were used as controls (n = 3). DENV2 capsid mRNA levels were normalized to mouse or human actin
levels, respectively. Human actin primers were used to determine the actin levels in Vero cells.
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Figure 11. Role of HSP70 in A. albopictus EV-Mediated DENV2 Transmission.
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Figure 11. Continued.
(A and B) QRT-PCR analysis showing expression of A. albopictus- HSP70 isoform-1 (Accession number
JN132154) (n = 6) or expression of HSP70 isoform-2 (Accession number XM_019672019) (n = 6) in
C6/36 cell lysates collected from uninfected (UI) or DENV2-infected (I) (MOI 5; 72 hpi) groups. Samples
analyzed from 24, 48, and 72 hpi are shown for both isoforms.
(C) XM_019672019 levels in EVs derived from DENV2-infected (MOI 5) C6/36 cells at 24, 48 and 72 hpi
is shown. Uninfected C6/36 cell-derived EVs collected at similar time points serve as control (n = 6).
(D) Immunoblots showing expression levels of HSP70 in EVs derived from uninfected or DENV2- infected
(MOI 5) samples and total cell lysates is shown from different time points (24, 48 and 72 hpi) of infection.
Total protein profiles from Coomassie stained gel images serve as controls for both cell and EVs lysates.
HSP70 molecular mass is indicated as 70 kDa.
(E) QRT-PCR analysis showing expression of HSP70 isoform-2 in C6/36 cells treated with VER-155008
inhibitor for 4 h followed by DENV2 (MOI 5, 72 hpi) infection is shown. Also, EVs lysates collected from
these C6/36 cells treated and infected (as shown above) is shown for comparison (n = 4).
(F) DENV2 load in C6/36 cells or EVs is shown. C6/36 cells were treated with VER-155008 inhibitor at
indicated doses followed by DENV2 infection (MOI 5, 72 hpi) and EVs were derived from the same cells
(n = 4).
(G) Reinfection of naïve C6/36 cells with EVs derived from VER-155008 inhibitor treated and DENV2infected (MOI 5, 72 hpi) or EDS is shown. C6/36 cells were treated with mock (DMSO) serve as controls
in (E, F and G) (n = 4). HSP70 or DENV2 capsid mRNA levels were normalized to mosquito actin levels.
The p value determined by Student’s two-tail t test is shown. The qPCR analysis for this figure was
performed by Mr. Wenshuo Zhou.
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Figure 12. Alignment and Phylogenetic Analysis of A. aegypti Tsp29Fb.
(A) The deduced A. aegypti Tsp29Fb amino acid sequence alignment (with other orthologs) using
ClustalW program in DNASTAR Lasergene is shown. Residues that match are shaded in black color.
GenBank accession numbers for D. melanogaster tetraspanin 29Fb, M. musculus and H. sapiens CD63
sequences are shown. VectorBase accession numbers for A. aegypti and A. albopictus Tsp29Fb are
provided. Ruler on the top of alignment indicates number of amino acids. Total length of the amino acid
sequence is provided at one end of each sequence.
(B) Phylogenetic analysis was performed in DNASTAR by ClustalW slow/ accurate alignment method.
Scale at the bottom denotes amino acid substitutions per 100 amino acid residues.
(C) Domain analysis of A. aegypti Tsp29Fb primary amino acid sequence at PROSITE (ExPASy) is
shown. A. aegypti Tsp29Fb contain one highly conserved tetraspanin domain, 4 transmembrane regions,
4 myristoylation sites and 2 glycosylation sites.
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Figure 13. DENV2 Induces the Expression of Tsp29Fb, a Putative EV-Enriched Marker in Mosquito
Cells.
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Figure 13. Continued.
(A, B and QRT-PCR analysis showing expression of A. aegypti tsp29fb in uninfected (UI) or DENV2infected (I) whole mosquitoes at 24, 48, and 72 hpi (n = 4), or in EVs isolated from an uninfected or
infected (MOI 5) in vitro cell line or in Aag-2 whole-cell lysates at (n = 4).
(D and E) QRT-PCR analysis showing expression of A. albopictus tsp29fb in EVs isolated from
uninfected or infected (MOI 5) C6/36 cells or in whole-cell lysates at 24, 48, and 72 hpi (n = 8). DENV2
capsid mRNA or tsp29fb levels were normalized to mosquito actin levels. The p value determined by
Student’s two-tail t test is shown.
(F) Immunoblotting analysis showing levels of Tsp29Fb and viral E-protein in EV derived from uninfected
or DENV2-infected (MOI 5) C6/36 cells or in whole-cell lysates at 24, 48, and 72 hpi.
(G) Immunoblotting analysis showing presence of Tsp29Fb and viral E-protein in EVs derived from
uninfected or DENV2-infected (MOI 5, 72 hpi) C6/36 cells or in whole-cell lysates upon infection with
different viral doses (MOI 1–5) is shown.
(H and I) Immunoblotting analysis of Tsp29Fb IP proteins in RIPA or in 1 x PBS buffer with 4G2 antibody
showing detection of viral E-protein in EVs or whole-cells lysates derived from DENV2-infected (MOI 5, 72
hpi) C6/36 cells. Uninfected cells were used as controls in all assays. Gel images showing total protein
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profiles in (F–I) serve as loading control for respective immunoblots. Tsp29Fb and DENV2 E-protein
molecular mass is indicated as kilo Daltons.
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Figure 14. Tsp29Fb Co-Localizes with DENV2 E-protein and Does Not Precipitate with Actin.
(A) Fluorescent microscopic images of uninfected (UI) or DENV2-infected (I) (MOI 5) C6/36 cells at 72
hpi, probed with DAPI (blue), Tsp29Fb (green) and E-protein (red) is shown. Merged images show colocalization of E-protein with Tsp29Fb (yellow) (n = 5) and counter staining with DAPI. Scale bar indicates
200 μm.
(B) Immunoblotting analysis of Tsp29Fb immunoprecipitated proteins in RIPA buffer with actin
monoclonal antibody revealed no co-precipitation in either EVs or whole cells lysates derived from
DENV2-infected (MOI 5; 72 hpi) C6/36 cells. Uninfected cells were used as controls.
(C) Immunoblotting analysis of input lysates from DENV2-infected (MOI 5, 72 hpi) and uninfected C6/36
cells showing level of actin being present in the same lysates used for immunoprecipitation assay. Total
protein profile images showing Coomassie stained proteins serve as control. Expected actin molecular
mass is indicated as kDa.

38
A

B

Figure 15. PCR Amplification of A. aegypti Tsp29Fb DNA Fragment
(A) Agarose gel image showing amplification of A. aegypti tsp29fb DNA fragment used for synthesis of
dsRNA. Oligonucleotides were designed based on AAEL012532 sequence.
(B) Nucleotide sequence of A. aegypti tsp29fb dsRNA clone is shown.
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Figure 16. RNAi-Mediated Silencing or Antibody Blocking of Tsp29Fb or Treatment with GW4869
Inhibitor Affects DENV2 Burden in Mosquito Cells and EVs.
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Figure 16. Continued.
(A) QRT-PCR analysis showing expression of A. aegypti tsp29fb to reveal silencing efficiency or,
(B) viral burden in whole-cell lysates or EVs derived from DENV2- infected (MOI 2, 24 hpi) Aag-2 cells
treated with mock or Tsp29Fb dsRNA (n = 6).
(C) Immunoblotting analysis showing levels of A. aegypti Tsp29Fb or viral E-protein in whole-cell lysates
or EVs derived from DENV2-infected (MOI 2, 24 hpi) Aag-2 cells treated with mock or tsp29fb dsRNA.
(D and E) QRT-PCR (n = 3) or,
(F) immunoblotting analysis showing viral burden in EVs or whole-cell lysates derived from DENV2infected (MOI 5, 72 hpi) C6/36 cells treated with Tsp29Fb antibody at different doses (of 5 and 10μg).
Untreated, infected (MOI 2, 72 hpi) C6/36 cells were used as controls in (D–F).
(G) QRT-PCR (n = 4) or,
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(H) immunoblotting analysis showing viral burden in EVs or whole-cell lysates derived from DENV2infected (MOI 2) C6/36 cells at 72 hpi or at 18 or 24 hpi. Samples in (H) were treated with GW4869
inhibitor at different doses (of 5–20 μM).
(I) QRT-PCR analysis showing viral burden in naïve C6/36 cells at 48 hpi, (reinfection) upon treatment
with EVs derived from DMSO- or GW4869-treated DENV2-infected (MOI 2, 72 hpi) C6/36 cells (n = 4).
(J) QRT-PCR analysis showing viral load at 48 hpi in HUVEC cells in a transwell assay performed with
C6/36 cells (in upper chamber) and naïve HUVEC cells (in lower chamber) treated with EVs derived from
DENV2-infected (MOI 2, 72 hpi) C6/36 cells (25 μL, in upper chamber) in the presence or absence of
GW4869. C6/36 cells infected with DENV2 laboratory stocks were used as control (n = 4). The p value
determined by Student’s two-tailed t test is shown.
(K) Immunoblotting analysis of Tsp29Fb IP proteins with 4G2 antibody and EVs or whole-cell lysates
derived from DMSO- or GW4869-treated infected (MOI 2, 24 hpi) C6/36 cells. Tsp29Fb and DENV2 Eprotein molecular mass is indicated in kilo Daltons. Coomassie-stained gel images showing total protein
profiles in (C, F, H, and K) serve as a loading control for the respective immunoblots.
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Table 1. Oligonucleotides Used for DENV, tsp29fb, hsp70 and actin

Primers (5'-3')
AATATGCTGAAACGCGAGAGAAACCGCG
CTCTTCAGTATCCCTGCTGTTGG
AATATGCTGAAACGCGTGAGAAACCGTG
CTAGCCAAGACTCCTGCTGTTGG
CCATGTACGTCGCCATCCA
GCGGTGGCCATTTCCTG
AGTTGTTAGTCTACGTGGACCGACA
GAGTGGCAGGTTGTTTGGCT
CAGGAGGAAGCTGGGTTGACA
GTCCCGGCTCTACTCCTATGATGA
GTCAACCCAATCGTAACAGAAAAAGA
CTCCAGAGGGTGTGTGACTTTG
CGATATGGGTTATTGGATAGAAAGTG
GTTGGTTCTTGAAAGGGTTGTTAGA
CCTCACAGCAGAAAGCGGA
GACTATGGCCGGAAGGTATCTCT
CAATCCAGAGATCGAAGATGACA
GCCTTCAGCTGCCACTCTGT
CAGAGCGTGAAAAGGTGGATG
GAGCTGCTGTGAGAGTTATGGGGT
GTTAATGGGTCTTGGGAAAGGA
GGCTCCTCCATATTTCCTTTGTAGT
CCCAATTTTGCATAAAGGTTCTCA
CTTCTAGTGTGATTCTTGTGTCCCA
CTTGAGTGGAGTGGAAGGAGAAG
CCCAATCAATGAGCCGCA
GGAACAGGGTGTGGATTCAAGA
AGAACCTGTTGATTCAACAGCACCA
GGACGAGAAGGACGGTGAGA
GCACAGCGCGGTTGTCCT
GACGGCGGCATTGGCA
CCGCTCGGCATTGGTGA
CGCCGGCCCACCTGAT
GAGTTCGGCGAACCATCTCCT
CGCCGGCCCACCTGCT
GATATTAATCATAGCGGTGCTCTCCT
CCAGATCTGACCGGAACGACCTCAACA
CGGGTACCCATGGCGGTGCTTTCCTTGA

Purpose
Dengue 2, QPCR
Dengue 2, QPCR
Dengue 3, QPCR
Dengue 3, QPCR
Mosquito actin
Mosquito actin
Dengue 2, fragment 1 amplification
Dengue 2, fragment 1 amplification
Dengue 2, fragment 2 amplification
Dengue 2, fragment 2 amplification
Dengue 2, fragment 3 amplification
Dengue 2, fragment 3 amplification
Dengue 2, fragment 4 amplification
Dengue 2, fragment 4 amplification
Dengue 2, fragment 5 amplification
Dengue 2, fragment 5 amplification
Dengue 2, fragment 6 amplification
Dengue 2, fragment 6 amplification
Dengue 2, fragment 7 amplification
Dengue 2, fragment 7 amplification
Dengue 2, fragment 8 amplification
Dengue 2, fragment 8 amplification
Dengue 2, fragment 9 amplification
Dengue 2, fragment 9 amplification
Dengue 2, fragment 10 amplification
Dengue 2, fragment 10 amplification
Dengue 2, fragment 11 amplification
Dengue 2, fragment 11 amplification
JN132154, A. albopictus hsp70, QPCR
JN132154, A. albopictus hsp70, QPCR
XM_019672019, A. albopictus hsp70-like,
QPCR
XM_019672019, A. albopictus hsp70-like,
QPCR
AAEL012532 QPCR and RNAi analysis
AAEL012532 QPCR and RNAi analysis
AALF02630 QPCR
AALF02630 QPCR
AAEL012532 dsRNA fragment cloning
AAEL012532 dsRNA fragment cloning
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DISCUSSION

This study has established that dengue virus is able to use extracellular vesicles
as vehicles for transmitting itself from infected mosquito cells to various naïve recipient
cells. Viruses other than DENV that are implicated in the use of EVs for transmission
include the human immunodeficiency virus, hepatitis C virus and Langat virus
(Ramakrishnaiah et al., 2013; Wiley and Gummuluru, 2006; Zhou et al., 2018). These
evidences supported our hypothesis that dengue virus, which is a flavivirus with a
positive-sense single stranded RNA genome might also be transmitted through similar
mechanisms. The multiple pieces of evidence generated in this work are shown starting
with Figure 3 & 5 that show A. albopictus cells (C6/36) can be infected with DENV2 & 3
and that EVs isolated using techniques described in Figure 4, also carry the viral RNA
and protein at different time points post infection. Figure 7 further provides evidence that
the entire DENV2 genome is present in the EVs derived from infected C6/36 cells. The
genomic RNA of flaviviruses is single-stranded, ∼11 kb in length and is infectious with

positive polarity, encoding the viral proteins required for RNA replication (Apte-

Sengupta et al., 2014; Gritsun et al., 2014). The abundant amount of E-protein and viral
RNA in C6/36 EVs in comparison with the cell lysates suggests package of higher
amounts of viral molecules for transmission to human and other vertebrate host cells.
The dissemination of infectious EVs within mosquitoes from hemolymph to the salivary
glands and subsequently to the mosquito saliva may efficiently facilitate the
transmission of the infectious viral RNA and proteins to the vertebrate host through an
infected mosquito bite during blood feeding. These data suggest that the full-length
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genomes of other serotypes of DENVs and perhaps related flavivirus genomes are
contained in arthropod EVs for transmission. In addition, a previous study from the
Sultana lab has shown that the tick-borne Langat virus and mosquito-borne West Nile
Virus (other members of Flaviviridae) RNA and proteins are also contained inside
Ixodes scapularis tick or mouse neuronal cell derived exosomes and that exosomemediated Langat virus and West Nile Virus transmission to recipient cells is through
receptor-dependent endocytosis (Zhou et al., 2018). We hypothesize that the presence
of DENV2/3 RNA and proteins inside EVs could facilitate the viruses to escape the
host’s antibodies, immune cells and defense response. This could allow enhanced
fusion of EVs with naïve recipient cells through clathrin-dependent, receptor-mediated
endocytosis for the establishment of infection.
In the multiple cryo-EM analyses (Figures 5 and 7), the presence of intact virions
inside or outside the EVs was not detected. One of the reasons for this could be that all
our analyses were performed 72 hpi. To make virus preparations, concentrated
supernatants from longer times of infection (7–14 dpi) with higher titers (109 to 1012
PFU/mL) and centrifugal forces of 200,000 × g have been used (Fragnoud et al., 2015)
that are not similar to the one used for our EV preparations (Figure 4). To avoid longer
incubation days and peak of infection resulting in cell death, we performed all our
experiments at 72 hpi. It is possible that longer times of infection (days 7–14 pi) may
reveal intact mature viruses in EVs. Mosquito cell-derived EVs were found to have a
wide ranging size distribution, varying from diameters of 30–150 nm (exosomes) and
sizes of 150–350 nm (microvesicles). The quantification of EVs using the cryo-EM
microscopy data suggested a smaller number of microvesicles in the DENV2-infected
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group compared with the number of EVs from the uninfected group (Figure 6). In
addition, the infected samples had an abundance of smaller EVs or exosomes of 0-100
nm size. The DG-EVs isolation showed the presence of HSP70, an EV-enriched/
marker protein confirming the presence of EVs. Detection of DENV2 E-protein in denser
fractions, along with HSP70 shows that the EVs, with size ranges of 50–100 nm carry
the highest amount of viral E-protein (Tauro et al., 2012).
Higher expression of HSP70 in infected samples could be due to the fact that EV
marker presence has been correlated with a general increase in vesicle secretion, or
rather with an increase in biomarker density on the surface of vesicles (Figure 5) (Chia
et al., 2017; Rupert et al., 2017). The reference to the total protein concentration
(determined by the BCA technique) each time has given us very reliable and consistent
results with the routine isolation of EVs (Figure 6). Negligible differences in the viral
loads in the 4G2 antibody-bead binding assay (Figure 8) suggests that E-protein is
contained exclusively inside the EVs. If E-protein or viral particles were present outside
the EVs as contaminants, the 4G2 antibody would bind E-protein, resulting in lower viral
loads in comparison with the isotype antibody-treated or untreated controls. Treatment
of DENV2 viral stocks with 4G2 antibody showed binding of surface-exposed E-protein,
but not in the EV group, as E-protein was contained in the lumen of EVs and hence was
unavailable to bind to the 4G2 antibody. RNase A-treatment assays were in agreement
with the antibody-bead binding assay that further suggests no viral RNA was bound to
the exterior of the EVs or was not present as a contaminant in our EV preps. If viral
RNA was present in PBS suspensions containing EVs, we should expect an enhanced
viral load in samples not treated with RNase A in comparison with the treated group.
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These data are further supported by native-PAGE immunoblotting with 4G2 antibody
and ELISAs that showed more intense signal in the Triton X-100 detergent–treated
group in comparison with the untreated controls. Native-PAGE analysis indicated
detection of either higher complexes of E-protein as dimer or oligomers or perhaps the
presence of viral polyprotein (at higher molecular mass) under non-reducing conditions
and in the native state. The observation of lower molecular mass of E-protein upon
Triton X-100 treatment is possibly due to breakdown of the viral polyprotein.
Figure 9 and 10 firmly establish that EVs derived from infected mosquito cells
infectious, confirming the observations in a recent publication from Dr. Sultana’s
laboratory (Zhou et al., 2018). Naïve recipient cells exposed to EVs in contrast with the
EDS showed a much higher load of dengue indicating that the majority of the infectious
agents are contained within the EVs at 72 hpi. These data show that mosquito derived
infectious EVs are able to establish infection in cells that they would encounter during
the early stages during an in vivo infection of a vertebrate host i.e. human skin
keratinocytes, murine dendritic cells as well as human vascular endothelial cells.
Perhaps the viruses quickly insert their genome through EVs in the early stages of the
infection and then when it has enough copies, the viremia with detectable mature virions
occurs at later stages.
To identify a molecular player facilitating receptor-mediated endocytosis of
infectious EVs, we first looked at some EV markers. Starting with HSPs which include
both constitutive and stress-inducible members that interact with native and denatured
proteins to facilitate the proper folding of native proteins or refolding of the denatured
proteins (Lancaster and Febbraio, 2005; Takeuchi et al., 2015). The presence of
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mosquito HSP70s have been documented to increase during several environmental
stresses, and several hsp genes are upregulated following a blood meal in mosquitoes
(Benoit et al., 2010; Sanders et al., 2003). Upregulation of HSP70 homologs upon
DENV2 infection suggested a protective role of this molecule during DENV2-induced
stress. Figure 11 shows the presence of only one isoform (XM_019672019) of HSP70 in
EVs suggesting its importance possibly in the chaperone activity inside EVs. The lack of
any effect on DENV2 loads in EVs upon treatment with VER-155008 HSP70 inhibitor
suggests that HSP70 is perhaps not required for DENV2 replication in cells and release
into EVs. In addition, no differences in the DENV2 loads in naïve C6/36 cells upon
treatment with infectious EVs derived from HSP70-inhibitor–treated and DENV2infected C6/36 cells suggests that HSP70 may not be required for EV-mediated
transmission of DENV2 RNA and proteins.
We then identified another EV associated protein, the transmembrane/
tetraspanin domain containing glycoprotein Tsp29Fb in A. aegypti mosquito cells and
EVs derived from both A. aegypti (Aag-2) and A. albopictus cells (C6/36) (Figure 12).
Figure 13 shows the up-regulation of Tsp29Fb upon DENV2 infection at both
transcriptional and translational levels, in vivo, in cells and EVs confirmed the link
between this molecule and DENV2 infection in mosquitoes. Identification and
characterization of this arthropod EV-enriched marker provides information on a
molecular determinant that facilitates transmission of DENV2 from vector to the
vertebrate host. Furthermore, the direct interaction and association of Tsp29Fb with
DENV2 E-protein suggests a potential role of this molecule in mediating DENV2 entry,
replication and transmission via the mosquito endo-exosome pathway. The enriched
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signal for E-protein in both IP assays could be because of the abundance of Tsp29Fb to
bind with DENV2 E-protein in cells compared with the EVs.
Silencing of Tsp29Fb in Aag-2 cells showed a significant reduction in DENV2
cellular loads and significantly reduced export of the viral RNA and E-protein in EVs
(Figure 16). Functionally blocking of Tsp29Fb clearly showed reduced DENV2 loads in
both EVs and C6/36 cells. These data clearly showed the prominence of this arthropod
molecule in mediating DENV2 replication, release, and transmission via EVs. The use
of exosome release inhibitor GW4869 at lower tested doses of 10–20 μM further
confirmed that DENV2 transmission is mediated via EV release. The exosome inhibitor
treatment significantly reduced the DENV2 capsid mRNA and E-protein. In addition,
blocking of EVs/ exosome release by GW4869 reduced the infectious viral RNA and
protein transport, thereby dramatically blocking the transmission to human blood
endothelial cells. The direct interaction of the viral E-protein with Tsp29Fb was also
affected by treatment with GW4869, suggesting a role for this arthropod marker in the
EVs/ exosome release pathway. It would be an interesting future avenue to investigate
the mechanism of this viral inhibition through blocking the release of EVs from arthropod
saliva. The finding that inhibition of EVs/ exosome release/ exocytosis upon GW4869
treatment in arthropod cells suggests the presence of neutral sphingomyelinase in
mosquitoes.
Overall, this study suggests that inhibition of mosquito tetraspanin domaincontaining glycoprotein Tsp29Fb or inhibition of EV/ exosome release through the
GW4869 inhibitor treatment can both be potential therapeutics to block transmission of
DENV2 and perhaps other mosquito-borne flaviviruses.
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METHODS AND MATERIALS

Cell Culture and Infection of In Vitro Cell Lines
Aedes albopictus (C6/36 cells) and Aedes aegypti (Aag-2) cell lines were grown
in either MEM medium or in Schneider’s insect medium with 10% FBS, respectively.
Vero and HaCaT cells were grown in complete DMEM medium containing 10% heatinactivated FBS. Mouse monocyte-derived dendritic cells isolated from bone marrows of
C57BL/6 wild-type mice were plated in RPMI medium containing 10% FBS and 10
ng/mL of GM-CSF (Peprotech). Four days later, cells were re-plated in the same
medium for experiments. HUVEC cells were grown in human lung MVEC medium
(M199 medium; SIGMA, containing 150 mg ECGF- bovine brain extract and 20% FBS)
and as per the instructions from Dr. Catravas laboratory. All culture medium and
required supplements were purchased from Invitrogen/ThermoScientific Inc.
To determine infection, 1 x 105 of C6/36 or Vero or mouse-DCs or
HaCaT/HUVEC cells were seeded in 12-well plates, infected with Multiplicity Of
Infection (MOI 5) of DENV2 (TVP2176 provided by Dr John Anderson and New Guinea
C strain) or DENV3 (DENV-3/US/BID-V1619/2005). Cells were collected at different
time points (24, 48, 72 and 96 hpi) and processed for RNA extraction. Briefly, for reinfection experiments with EV fractions containing infectious DENV2 RNA and proteins,
1 x 105 C6/36 cells or HaCaT/HUVEC cells or mouse dendritic cells were co-incubated
with 25 µL of mosquito cell-derived EV fractions (that corresponds to 126 µg of total EV
protein as estimated by Bradford assay). We used 625 µL (same ratio) of EV depleted
supernatant (EDS) fraction from C6/36 cells (collected from the step before PBS
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washes during EV isolation, See Figure 4B). For re-infection studies, mosquito or
mammalian cells (infected via EVs or EDS fractions collected from 72 hpi. DENV2infected C6/36 cells) were collected at 72 hpi, and processed for RNA extractions. The
IBC number for the all the cell culture performed for this study is 15-014.

Cryo-Electron Microscopy
Purified concentrated suspensions of EVs in PBS were vitrified on carbon holey
film grids (R2x2 Quantifoil®; Micro Tools GmbH, Jena, Germany; or C-flat™,
Protochips, Raleigh, North Carolina) and as previously described (Sherman et al., 2006,
2009). EVs were applied to the holey films in a volume of ca. 3 µl, blotted with filter
paper, and plunged into liquid ethane cooled in a liquid nitrogen bath. We used
computerized Vitrobot plunger (FEI, Hillsboro, OR) for freezing. Frozen grids were
stored under liquid Nitrogen and transferred to a cryo-specimen holder (70 deg. 626,
Gatan, Inc., Pleasanton, CA, or 2550 Cryo-Tomography holder, E.A. Fischione
Instruments, Inc., Export, PA) under liquid Nitrogen before loading into a JEOL 2200FS,
or a JEOL 2100 electron microscopes (JEOL Ltd., 3-1-2 Musashino, Akishima, Tokyo
196-8558, Japan). JEOL 2200FS was equipped with in-column energy filter (omega
type) and a field emission gun (FEG); JEOL 2100 had a LaB6 filament, both were
operating at 200 keV. Grids were maintained at near-liquid Nitrogen temperature (-172
to -180°C) during imaging. Preliminary screening and imaging of EVs was done using a
4k x 4k Gatan US4000 CCD camera (Gatan, Inc., Pleasanton, CA), and final imaging
was done at indicated 40,000x magnification with a 5k x 4k Direct Electron Detector
Camera (DE-20, Direct Electron, Inc., San Diego, CA) using a low-dose imaging
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procedure. An in-column omega electron energy filter was used during imaging with a
zero-loss electron energy peak selected with a 20 eV slit. Images were acquired with a
ca. 20 electrons/Å2 dose; the pixel size corresponded to 1.5 Å on the specimen scale.
We used a 2.0 – 2.3 µm defocus range for imaging. Individual EV images were acquired
from three independent isolated batches. For quantitation of EV size ranges, we
manually analyzed the sizes using scale bar from cryo-EM images and counted EVs of
different sizes per image in each group. Three independent estimations and counts
were performed without any bias. Percentages (for size determination) were calculated
based on the total number of EVs in each size range.

OptiPrepTM Density Gradient EV (DG- EVs) Isolation
2 x 108 or 1 x 109 of C6/36 cells were infected with either 2 or 5 MOI of DENV2,
respectively or were maintained as uninfected controls. The detailed protocol is shown
in Figure 4A or described in (Zhou et al., 2018). Supernatants (20 mL) from
uninfected/infected cells were collected and centrifuged at 4°C (480 x g followed by
2000 x g for 10 min each to remove cell debris and dead cells). Cell culture
supernatants were (either filtered through 0.22 µm and then) concentrated to 2 mL
using the Corning Spin-X UF concentrators or centrifugal filter device with a 5 k nominal
molecular weight limit (NMWL). 15 mL volume of discontinuous gradient of 40% (w/v),
20% (w/v), 10% (w/v) and 5% (w/v) solutions of iodixanol was prepared from the stock
solution of OptiPrepTM 60% (w/v) of aqueous iodixanol (Axis-Shield PoC, Norway) with
0.25 M Sucrose/10 mM Tris, pH 7.5. Polycarbonate bottles were loaded with
discontinuous gradient of iodixanol (4 mL each of 40% (w/v), 20% (w/v), 10% (w/v) and
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3 mL of 5% (w/v) from bottom to top). Concentrated cell culture supernatants (1-2 mL)
were overlaid onto the top of the gradient, and centrifuged at 100,000 x g for 18 h at
4°C. Either 6 or 12 (12 in case of 0.22 µm filtered group) individual uninfected or
infected fractions of ~2.6 mL or 1.3 mL (filtered) were collected (from top to bottom)
manually (with increasing density of iodixanol) and diluted with 5 mL of sterile PBS.
Fractions were centrifuged at 100,000 x g for 3 h at 4°C, followed by another PBS wash
and spin at similar centrifugal forces. DG-EVs fractions were resuspended in 100 µL of
PBS and stored at -80°C until further analysis. For cryo-EM images obtained from
different fractions, EVs were isolated from DENV2-infected (MOI 5, 72 hpi) C6/36 cells
(2 x 109) and samples were immediately shipped on dry ice to imaging facility. Similar
processing methods were used to collect images from each fraction.

Isolation of EVs from Cell Culture Supernatants
EVs were also isolated by differential ultracentrifugation method (Tauro et al.,
2012; Théry et al., 2006; Zhou et al., 2018). EVs isolation procedure and modifications
are schematically shown in Figure 4B and respective figure legend. Briefly, 2 x 106
C6/36 or 1 x 106 Aag-2 cells were seeded for EVs isolation in respective medium for
overnight. Next day, cells were changed to respective medium containing bovine
exosome-free FBS (Systems Biosciences Inc; SBI). After 4-5 hour of medium
replacement, cells were infected with DENV2 (MOI 5). Cell culture supernatants were
spun as shown in Figure 4B. Increased centrifugation times and rotor types are shown
to improve EVs yield and purity (Cvjetkovic et al., 2014) and, hence were used for
isolation of EVs from mosquito cells. Supernatants were spun at 100,000 x g, for 155
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min. Supernatants collected after this spin served as EVs depleted supernatant (EDS)
fractions (used as controls in our study and indicated with asterisk in Figure 4B). The
pellet containing EVs and any contaminants were washed with ice-cold PBS and spin at
100,000 x g, for another 155 min. Resulting EVs pellet is referred as EVs fraction in this
study. Freshly prepared EVs pellets were resuspended in PBS and stored frozen at 80°C for subsequent evaluations and assays or were directly resuspended in RNA lysis
buffer (Bio-Rad) or modified RIPA buffer (G-Biosciences, BioExpress) for total RNA or
protein extractions, or were immediately used in RNaseA and Triton-X-100 treatment
studies, respectively. We also isolated EVs from mosquito cells using the commercial
total EVs isolation reagent and extracted total RNA and proteins using total EVs RNA
and Protein Isolation kit (Invitrogen/ThermoScientific Inc.) and as per the manufacturer’s
instructions.

PCR-Amplification of Full Length DENV2 Genome
The cDNA generated from total RNA isolated from C6/36 cell derived EVs was
used as template for the amplification of DENV2 genome. The oligonucleotides used for
the amplification are shown in Table 1. We amplified fragments 1-10 of variable sizes by
regular PCR and fragment 11 (3’ end) by touchdown PCR. Regular PCR was performed
with the following conditions: Initial denaturation at 95 ºC for 4 min followed by 40 cycles
of steps including 95 ºC for 10s, 58ºC for 20s, and 72ºC for 1min. Fragments 1-10,
amplified products of following sizes 1102 bp, 1110 bp, 1124 bp, 1114 bp, 1118 bp,
1141 bp, 1104 bp, 1135 bp, 1110 bp and 1048 bp, respectively (Figure 7A). The
fragment 11 amplified a product of 717 bp by touchdown PCR, performed with method
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as described (Korbie and Mattick, 2008) . The PCR reactions were later run on 1%
agarose gels, imaged using the Chemidoc MP imaging system, and processed using
Image Lab software obtained from the manufacturer (Bio-Rad).

RNA Extraction, cDNA Synthesis, and qRT-PCR Analysis
RNA from mosquito - C6/36 cells and Aag-2 cells, mouse monocyte-derived
dendritic cells, HaCaT cells, Vero and HUVEC cells infected with various MOI of DENV2
or uninfected controls at indicated time-points pi, was extracted using Aurum Total RNA
Mini kit (Bio-Rad) and following manufacturer’s instructions. RNA was converted to
cDNA using the Bio-Rad iScript cDNA synthesis kit. The generated cDNA was used as
template for the amplification and determination of the viral burden. For detection of
DENV2 RNA, published forward and reverse primers for dengue virus (Serotype 2)
were used (Sultana et al., 2009). For DENV3 RNA detection, we used specific primers
designed for Serotype 3, shown in Table 1. To normalize the amount of templates,
either mosquito or mouse or human beta actin amplicon were quantified with published
primers (Sultana et al., 2010, 2012). Primers for beta-actin were used in parallel for
qRT-PCR normalization. Equal amounts of mosquito or mouse or human cDNA
samples were used in parallel for beta actin and DENV2 capsid gene.
The ratio of DENV2 capsid gene copy/beta actin gene copy was used as an
index to determine the rate of infection in each analyzed sample. In some experiments,
with undetectable amounts of actin in EVs samples, we normalized to the total RNA
loads. QRT-PCR was performed using iQ-SYBR Green Supermix (Bio-Rad, USA).
Standard curves were prepared using 10-fold serial dilutions starting from standard 1 to
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6 of known quantities of actin or DENV2 capsid gene fragments and qRT-PCR reactions
were performed as described (Sultana et al., 2009, 2010, 2012). Primer sequences for
all mosquito genes (including both hsp70 isoforms, tsp29Fb and actin) used in this
study are provided in Table 1. For RNase A treatment, we isolated fresh EVs from either
uninfected or DENV2-infected C6/36 cells (2 x 106), distributed the infected EVs as
treated (5 µg/mL RNase A, 37°C for 15 min) or untreated groups. For laboratory virus
stocks (generated by collecting cell culture supernatants from 14 days post infection
C6/36 cells and held as frozen stocks), similar treatments with RNase A were performed
on DENV2 (5 MOI). Naïve C6/36 cells (2 x 105) were infected (72 hpi) and either treated
or untreated DENV2-infected EVs samples (25 µL) were processed for RNA extraction
and qRT-PCR analysis. Untreated EV samples from uninfected group served as internal
controls.

Protein Estimation and Immunoblotting
2 x 106 of C6/36 or Aag-2 cells was seeded in six well dishes/plates for overnight.
Next day, we changed the media containing bovine EVs free FBS (Systems
BioSciences Inc.; SBI). After 4-6 hours of media replacement, cells were infected with
DENV2/DENV3 (MOI 5). For EVs quantitation assay, C6/36 cells were plated in six well
plates at densities of 104, 105, 106, 107, and 108 and followed by infection with DENV2
(MOI 5, 72 hpi). Uninfected cells plated with similar densities were used as controls for
estimation of total number of EVs. Cell culture supernatants were collected (at 72 hpi)
and processed for EV isolation. EV fractions were collected after PBS wash and the
adherent cells collected from the same plates (washed twice with 1 x PBS), were all

55
resuspended in modified RIPA buffer. Total protein amounts were estimated using
Bradford assay (BCA kit from Pierce/ThermoScientific Inc.) as three replicates. Total
cell and EV lysates (30 µg) were separated on 12% or 4-20% SDS-PAGE gradient
stain-free gels (Bio-Rad or NuSep; BioExpress) or processed for Coomassie blue
staining. Followed by gel electrophoresis, blots were blocked in either 5% milk buffer or
BSA and probed with either highly cross-reactive 4G2 monoclonal antibody (obtained
from Dr. Michel Ledizet, L2 Diagnostics or Millipore, Sigma) to detect DENV2 or DENV3
E-protein (obtained from BEI resources) or human CD63 (Santa Cruz Biotechnology,
Inc.) or human HSP70 (Cell Signaling Technologies, Inc. or Bio-Rad) or monoclonal
anti-DENV2 NS1 (Abcam) antibodies or actin monoclonal antibody (Abcam), followed
by mouse or rabbit monoclonal HRP-conjugated secondary antibodies (Santa Cruz
Technologies, Inc.), respectively. Total protein profiles were images obtained from
either stain free gels, Coomassie stained gels, or Ponceau S stained blots that served
as loading controls. Antibody binding was detected with WesternBright ECL kit
(Advansta, BioExpress/VWR). Blots were imaged using Chemidoc MP imaging system
and processed using Image Lab software obtained from the manufacturer (Bio-Rad).

E-Protein-Antibody-Beads Binding Assays
Freshly isolated EVs from 2 x 106 C6/36 cells (infected with MOI 5) were seeded
on plates for overnight incubation, changed to exosome-free FBS medium after 4h,
followed by infection with DENV2 for 72 hpi. EVs collected were resuspended in PBS
and grouped into three categories as; untreated, treated with 4G2 antibody (that
recognizes DENV2 E-protein) or relevant isotype control antibody (R & D Systems)
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groups. In a similar way, we used DENV2 laboratory virus stocks (with known titers; 5
MOI, suspended in MEM complete growth medium from C6/36 cells), also grouped as
three categories (untreated, 4G2 or isotype antibodies treated, respectively). EVs
fractions or DENV2 laboratory virus stocks were incubated for 1 h. (RT) with respective
antibodies followed by incubation (4°C) with protein A/G agarose beads (Pierce/
ThermoScientific, Inc.) for another 30 min. The antibody-bead complexes were spun
(13k rpm) at 4 °C for 30 min and supernatants were collected and lysed in RNA lysis
buffer, processed for RNA extractions, followed by cDNA synthesis and qRT-PCR to
analyze the DENV2 loads from either EVs samples or DENV2 laboratory viral stocks.

Native-Poly Acrylamide Gel Electrophoresis (PAGE)
For this analysis, we seeded C6/36 cells (2 x 106) in complete MEM medium for
overnight incubation, then replaced with exosome-free FBS medium followed by
infection with DENV2 (MOI 5) for 72 hpi. Cell culture supernatants were processed for
isolation of EVs (Figure 4B) and resuspended in PBS. EVs were separated as three
groups (from the same preparations); group that was either held as untreated on ice, or
group treated with Triton-X-100 (0.1%; 30 min, RT) or group treated with three cycles of
freezing at -80°C (for 1 h.) followed by thawing at 4 °C. After treatments, protein lysates
were prepared for non-reducing and non-denaturing sample conditions (62.5 mM TrisHCL, pH 6.8, 25% Glycerol and 1% Bromophenol blue) that maintained the proteins
secondary structures and native charge density. Gels were pre-run for 60 min in gel
running buffer (25 mM Tris and 192 mM Glycine). Uninfected or DENV2-infected EVs
preparations with treatments or untreated samples were separated on 12% Native-
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PAGE gel, transferred on to nitrocellulose membrane, probed with 4G2 antibody
followed by mouse monoclonal HRP-conjugated secondary antibody. Total protein
profiles (Ponceau S stained image) served as loading control. WesternBright ECL kit
(Advansta, BioExpress) detected antibody binding and blots were scanned using
Chemidoc MP imaging system as described for immunoblotting analysis.

Measurement of Relative Fluorescence
C6/36 cell-derived EVs (derived from 2 x 106 cells infected with DENV2 MOI 5;
72 hpi) were resuspended in PBS (250 µL/sample). EVs were plated as five replicates
of 50 µL each that corresponds to 254 µg of total EVs protein, as estimated by BCA
method. EVs fractions held in PBS were either treated with 0.1% of Triton-X-100 for 30
min or kept untreated. Samples were incubated with 4G2 monoclonal antibody (1:500
dilution) for 1 h, followed by three times washes with PBS and secondary Alexa-Fluor
594 mouse monoclonal secondary (1:2500 dilution) for 1 hour at RT. Relative
fluorescence was measured using a Fluorimeter (Tecan, USA) with excitation at 590 nm
and emission at 617 nm.

Enzyme Linked Immunosorbent Assay
Freshly isolated mosquito cell-derived EVs (from 2 x 106 of DENV2-infected MOI
5; 72 hpi cells) resuspended in PBS (250 µL/sample) were either treated with 0.1% of
Triton-X-100 for 30 min or kept untreated. Nunc grade ELISA plates were coated with
50 µL (that corresponds to 254 µg of total EVs protein as estimated by BCA method) of
untreated or Triton-X-100 treated- uninfected or infected samples for overnight at 4 °C.
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Samples were blocked with BSA and incubated with 4G2 antibody for 1 h, followed by
HRP-conjugated mouse monoclonal secondary antibody for another 1 h for detection
(Sultana et al., 2009). SureBlue TMB Microwell Peroxidase substrate and Stop solution
(KPL) were used following manufacturer’s instructions. After stopping the reactions with
TMB Stop solution, using a Multimode infinite M200 Pro Microplate reader (Tecan)
optical density was measured from triplicate samples in two independent experiments
and absorbance at 450 nm was recorded.

Viral Immunofluorescence Assay
Dilution assays were performed as described in (Schoepp and Beaty, 1984).
Briefly, C6/36 cells were seeded (at a density of 1 x 105 cells/well in 225 µL of MEM
complete medium) into 96 well plates. Cells were incubated overnight and treated with
either EVs fractions (20 µL; that corresponds to 101 µg of total EVs protein as estimated
by the BCA method) or EVs depleted supernatant fractions (EDS; 675 µL) for 24 hours.
Each of the group had six different dilutions (1-6) and at least 7-10 independent
replicates in addition to the uninfected negative controls. Data is shown from dilution 1
or 10 fold dilution (Figure 9A, 10A) or from dilution 3 or 1000 fold dilution (shown as
Figure 9A). Cells were fixed with acetone-PBS mixture (3:1, for 20 min at -20º C) and
plates were air dried, washed with 1 x PBS and blocked with 5% FBS-PBS-0.05%
Sodium Azide for 15 min at RT. E-protein was detected by incubation with 4G2 antibody
(for overnight at 4º C), followed by three washes with PBS. Samples were incubated
with Alexa-594 labeled mouse secondary antibody for 1 hour at RT, followed by washes
(3X) with PBS. Plates were analyzed using EVOS fluorescence system (Invitrogen or
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ThermoScientific, Inc.) and cells were scored for fluorescence or the presence or
absence of infection in comparison to the infected positive controls or uninfected
negative controls. Representative images from dilutions 10-1 and 10-3 are shown.

Plaque Formation Assays
Plaque assays were performed as described in (Sultana et al., 2009). EVs and
EDS, were tested for infectious dose and capability of DENV2 viral RNA replication and
formation of infectious plaques. Briefly, we seeded Vero cells in 6-well plates at
densities of 2 x 106 cells per well, allowed them to adhere and grow as monolayers
reaching 65-85% confluence (for ~24h.). EVs fractions containing unknown PFU
(plaque forming units) of DENV2 viral genomes collected from C6/36 cells (5 x 106 cells;
resuspended in 100 µL of PBS; 30 µL of this suspension) were used for plaque assays.
EVs free supernatants (600 µL) corresponding to similar amounts of EVs fractions were
used as controls. Serial dilutions (1:10, 1:100 and 1:1000) of the EVs or EDS fractions
were prepared in duplicate (from two independent experiments). Medium was removed
4 hpi, and warm 2% Seaplaque agarose (Lonza) overlay with complete MEM media (1:1
ratio) containing antibiotic and anti-mycotic solution (1% each; Sigma) was added.
Plates were incubated for 6-7 days, at 37°C, 5% CO2. Plaques were stained with 0.03%
Neutral Red (Sigma) for 4 h, and were counted on the same day or otherwise incubated
(inverted and covered in foil) for overnight, and then plaques were counted to determine
the viral titers during next day.
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Immunoprecipitation Assays
Mosquito whole cell and EVs fractions were collected (either in RIPA modified
protein lysis buffer containing protease and phosphatase inhibitors; SIGMA or in cold 1
x PBS) from uninfected and DENV2 infected (MOI 5) cells (2 x 108 cells, 72 hpi). Before
immunoprecipitation, lysates in RIPA buffer or samples resuspended in PBS were
precleared with protein A/G agarose beads (Pierce/ ThermoScientific, Inc.) at a 1:10
volume of 50% bead slurry and centrifuged at 12,000 rpm at 4ºC for 10 min.
Supernatants were collected and protein concentrations were determined using the
Bradford assay (BCA kit; Pierce/ ThermoScientific, Inc.). Samples were aliquoted as
input (20 µg shown in total protein profile as controls) or used for immunoprecipitation
(150-500 µg of lysates suspended in RIPA buffer or 500 µg of PBS suspended
samples). Lysates/PBS suspended samples were incubated with 5 µg of highly crossreactive human CD63 antibody (Santa Cruz Biotechnology, Inc.) that recognizes the
Tsp29Fb for overnight at 4ºC, followed by incubation with protein A/G agarose beads for
4 h to complex with antibody. Samples were washed thrice with cold 1 x PBS and beads
were resuspended in 40 µL of SDS sample Laemmeli buffer, boiled and loaded on 12%
SDS-PAGE gels. Immuno-precipitates were further processed for immunoblotting (as
described above) using the 4G2 antibody or actin monoclonal antibody (as control) to
detect DENV2 E-protein or actin precipitation with Tsp29Fb.

Immunofluorescence and Microscopy
1 x 105 C6/36 cells were plated on 18 mm coverslips in complete MEM medium
and allowed to adhere for overnight. Cells were infected with DENV2 (MOI 2) for 72 hpi.
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Uninfected and infected cells were fixed with 3.7% (wt. /vol.) paraformaldehyde (37ºC
for 20 min), permeabilized with 0.2% (vol. / vol.) Triton X-100 (10 min at room
temperature), and blocked with 3% bovine serum albumin (30 min at RT) in PBS,
respectively. Cells were immuno-stained with antibodies directed against human CD63
(that detect Tsp29Fb), or 4G2 (that detect DENV2 E-protein), and detected by antirabbit (human CD63) or mouse (4G2) secondary antibodies conjugated with Alexa Fluor
488 or 594, respectively. Cells were counterstained for nuclei with DAPI and were
detected below 300 nm wavelengths. Alexa Fluor conjugates and DAPI (obtained from
Invitrogen/ ThermoScientific, Inc.). Images were obtained using the EVOS Fluorescence
System (Invitrogen/ ThermoScientific, Inc.). Representative images are shown for coassociation between Tsp29Fb and DENV2 E-protein.

RNAi, dsRNA Synthesis and Transfections
A. aegypti Mosquito cDNA was used as template to amplify the DNA encoding a
fragment of Aedes tsp29Fb (Accession Number AAEL012532). Gene specific primers
containing the BglII and KpnI restriction enzyme sites used in the PCRs are shown in
Table 1. The amplified Aedes tsp29Fb fragment was purified by gel extraction (Using
Qiagen kit) and cloned into the BglII and KpnI sites of the L4440 double T7 Script II
vector (Sultana et al., 2010). Escherichia coli DH5alpha strain was used as a cloning
host. Using the MEGAscript RNAi kit (Applied Biosystems/ ThermoScientific) and user
manual instructions, we synthesized the dsRNA complementary to the Aedes tsp29Fb
sequence. For dsRNA transfections and silencing of Tsp29Fb, we plated 1 x 106 of Aag2 cells in complete medium (Schneider medium with 10% FBS and L-glutamine),
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allowed to adhere overnight, and used Lipofectamine transfections reagent (Invitrogen/
ThermoScientific). 750 ng of dsRNA mixed with Lipofectamine reagent was added on to
cells and 6 hours post addition, 2x complete medium was added and plates were further
incubated for additional 16 h. Cells were infected with DENV2 (MOI 2) and collected at
24 hpi for further analysis. Silencing efficiency of tsp29Fb was analyzed by qRT-PCR
and primers used are shown in Table 1.

Inhibition Studies
For inhibition of HSP70, we used the commercially available inhibitor VER155008 (obtained from SIGMA-Aldrich), a small molecule ATP-derivative inhibitor of
HSP70 (Lancaster and Febbraio, 2005; Takeuchi et al., 2015b). First we examined the
cytotoxic effects of the VER-155008 inhibitor and found no changes at the tested doses
of 10 and 20 µM, in comparison to the untreated group. C6/36 cells (2 x 106) were
plated in 6 well plates and treated with VER-155008 inhibitor for 4 h. (at tested doses of
10 and 20 µM) and followed by DENV2-infection (5 MOI) for 72 hpi. DMSO vehicle was
used as mock control as VER-155008 was dissolved in DMSO. Cell supernatants were
collected and processed for EVs isolation. Both cells and EVs were processed for RNA
extractions followed by qRT-PCR to detect hsp70 expression or DENV2 loads. For reinfection studies, we used EVs derived from VER-155008 inhibitor treated (for 4 h),
followed by DENV2-infected (MOI 5, 72 hpi) C6/36 cells. EDS fractions (used in similar
dilution to the use of suspended EVs per reaction) collected during EVs isolation (after
pelleting of EVs) served as control. Fresh C6/36 cells were incubated (re-infection) with

63
either EVs (derived from VER-155008 treated and DENV2 infected C6/36 cells) or EDS
fractions as controls.
For EVs inhibition studies, we used either the highly cross-reactive human CD63
antibody or GW4869, a cell permeable and selective commercial inhibitor for Neutral
Sphingomyelinase (N-SMase) (Santa Cruz Biotechnologies, Inc.) dissolved in DMSO.
For the inhibitor and antibody studies, EVs were isolated using the isolation reagent
(Invitrogen/ThermoScientific, Inc.). For antibody functional blocking studies, we treated
C6/36 cells (2 x 105) for 2 h with either 5 or 10 µg of CD63 antibody, followed by DENV2
infection (2 MOI) for 72 hpi. The untreated cells were used as controls. Cytotoxicity of
the inhibitor was first analyzed and cells did not show any toxicity at tested doses (1-20
µM). For the inhibitor studies, C6/36 cells (2 x 105) were plated in complete MEM
medium for overnight, changed to exosome-free FBS medium for 4 h and then treated
with the GW4869 inhibitor (with doses of 5, 10 15 or 20 µM) for another 4 h, followed by
DENV2 infection (2 MOI) for 72 hpi (in case of qRT-PCR analysis) or for 18 or 24 hpi,
for immunoblotting analysis. Cells were treated with similar volume of DMSO as control
groups. For infection kinetics using incubations with infectious EVs, HaCaT cells (2 x
105) were treated with DENV2-infected (2 MOI; 72 hpi) and 15 µM of inhibitor treated 2
x 105 of C6/36 cell-derived EVs and respective DMSO vehicle. Viral loads were
determined from HaCaT cells at 48 hpi by qRT-PCR analysis. For immunoprecipitation
assay, 1 x 107 of C6/36 cells were plated in regular complete MEM medium for
overnight, changed with exosome-free FBS medium for 4 h., treated with 15 µM inhibitor
or respective volume of DMSO as control, followed by infection with DENV2 (5 MOI) for
24 hpi. Cell culture supernatants were processed for EVs isolation and whole cells and
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EVs lysates (500 µg) were processed for immunoprecipitation with human CD63
antibody, followed by immunoblotting with 4G2 antibody to detect viral E-protein.

Transwell Assays
Transwell assays were performed to analyze the migration of infectious EVs
released from infected C6/36 cells (seeded in inserts; upper chamber) to uninfected/
naïve HUVEC cells seeded in 12-well plates (lower chamber). Sterile, polycarbonate
tissue culture-treated transwell inserts (12 mm insert size) with 0.4 µm microporous
membrane pore size were used in our assays (Corning/VWR). We plated, 2 x 105 C6/36
cells in inserts (upper chamber) and 2 x 105 HUVEC cells in 12-well plates (lower
chamber). Inserts with C6/36 cells were first kept in a separate 12-well plate containing
0.5 mL (in order to keep microporous membranes moist/wet) of MEM medium. Inhibitortreated group in transwell assays was treated with 20 µM of GW4869 inhibitor, and at
24 h post treatment, C6/36 cells were either infected with EVs containing DENV2 (25 µL
of the EVs fraction, that corresponds to 126 µg of total EVs protein as estimated by BCA
method, collected from independent batch of DENV2 (MOI 5; 72 hpi) infected C6/36
cells) or with DENV2 from laboratory viral stocks (MOI 5) prepared from infected C6/36
cell (14 days pi) culture supernatants. The laboratory viral stocks with known titers were
included as internal controls. Twenty-four hours post-infection, inserts with C6/36 cells
(with change of new media) were moved to 12-well plates containing uninfected or
naïve HUVEC cells. EVs containing viral RNA and proteins produced from C6/36 cells
were allowed to transmigrate and infect HUVEC cells (that were kept uninfected/naïve).
After, 48 h post-incubation (with infected C6/36 cells released EVs from inserts/upper
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chambers) HUVEC cells from lower chamber were washed twice with ice-cold PBS and
collected for RNA extractions, cDNA synthesis, and qRT-PCR to determine viral loads
from HUVEC cells.

Statistics
Statistical significance of difference observed in data sets was analyzed using
GraphPad Prism6 software and Microsoft Excel. The non-paired, two-tailed Student t
test was performed (for data to compare two means) for the entire analysis. Error bars
represent mean (+SD) values, p values of < 0.05 were considered significant in all
analysis. Statistical test and p values are indicated for significance.
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IXODES SCAPULARIS HSP70 IS RESPONSIBLE FOR VARIABLE
FIBRINOGENOLYSIS IN RESPONSE TO FEEDING ON HOSTS WITH DIFFERENT
IMMUNE STATUS

INTRODUCTION
Ixodes scapularis ticks are hard-bodied, obligate hematophagous arthropods.
These ectoparasites during the process of taking a blood meal can transmit many
pathogens to the host (Anderson and Magnarelli, 2008). Understanding molecular
interactions at the tick-host interface involve knowledge of the participation of host
defense mechanisms against tick infestations and counter measures employed by ticks
(Wikel, 2013). Tick feeding, egg production and viability affecting vector competence
can be influenced and modulated by the acquired resistance by the host through both
humoral and cellular immuno-regulatory pathways (Brossard and Wikel, 2004). Ticks
have many strategies for successfully avoiding the host response too. It involves the
suppression of the host’s antibody production, complement activation and cytokine
production from both antigen-presenting cells and T cells (Brossard and Wikel, 2004;
Francischetti et al., 2009; Hovius et al., 2008). Ixodes scapularis ticks have been known
to transmit pathogens like Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia
microti, Ehrlichia muris-like agent, Powassan virus and B. miyamotoi. The cause Lyme
disease, human anaplasmosis, babesiosis, human ehrlichiosis, encephalitis and
relapsing fever respectively (Anderson and Armstrong, 2012; Anderson and Magnarelli,
2008; Krause et al., 2014; Pritt et al., 2011).
To establish a successful feeding niche, commence blood feeding and
engorgement to repletion, I. scapularis ticks secrete a range of molecules through their
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saliva responsible for anti-hemostatic, anti-inflammatory, immunosuppressive and
immune-modulators against the host’s immunity pathways (Brossard and Wikel, 2004;
Hovius et al., 2008; Ribeiro and Francischetti, 2003; Wikel, 2013). Tick-borne
pathogens exploit these molecules present in tick saliva to enhance their ability to
transmit themselves and infect vertebrate hosts (Jones et al., 1989; Kročová et al.,
2003; Labuda et al., 1993). Many studies have explored the role of pathogens in the
modulation of tick gene expression (Neelakanta et al., 2010; Pal et al., 2004; Sultana et
al., 2010). However, the influence of different genetic or immune backgrounds of the
vertebrate hosts on tick biology and behavior during acquisition of a blood meal has not
yet been fully evaluated. Previous studies have reported significant variations in many
basic hematological and coagulation factors among many mouse strain backgrounds
(Emeis et al., 2007; Peters et al., 2002). It also been recently shown that T-cells
participate in coupling coagulation with inflammation implicating a direct role of host
immune status with coagulation (Green et al., 2015). These studies provide a strong
rationale to test whether different genetic or immune status of hosts influence feeding
and gene expression in Ixodes scapularis ticks. The results presented in this study
report that the host’s genetic background and/ or immune status does influence specific
tick gene expression that subsequently impact variable fibrinogenolysis during feeding
though the involvement of a tick HSP70-like molecule.
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RESULTS

Engorgement Weights Are Greater in Ticks Fed on Immunodeficient vs
Immunocompetent Mice
The first analysis was to determine if the immune status of hosts influence tick
engorgement weights. Two sets of age and background matched immunocompetent
(C57BL/6J and BALB/c) or immunodeficient (RAG-/- and SCID) mice with independent
housing conditions were ordered from two different vendors. These mice were infested
with uninfected I. scapularis larvae. After repletion, the engorgement weights of
individual larvae were measured using an analytical balance. The post-feeding weight of
larvae that fed on immunodeficient mice (0.499 ± 0.06 mg for RAG-/-; 0.517 ± 0.05 mg
for SCID) was significantly (P < 0.05) higher in comparison to the larvae that fed on
immunocompetent (0.479 ± 0.06 mg for C57BL/6J; 0.467 ± 0.06 mg for BALB/c) mice
(Figure 17A & B).

Presence of a Host Fibrin Degradation Product- D-Dimer Was Reduced in Ticks
Fed on Immunodeficient Mice
During feeding, ticks may acquire host proteins like fibrinogen and its
degradation products along with the vertebrate blood (Villar et al., 2016). Hence, we
decided to check for the presence of D-dimer, which is a degradation product of fibrin
(Cesarman-Maus and Hajjar, 2005), in the lysates of whole ticks fed on immunodeficient
vs. immunocompetent animals. The total protein profile of ticks that were fed on either
group of mice did not show any significant difference (Figure 18A & B). Immunoblotting
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showed negligible presence of D-dimer in the whole tick lysates obtained from ticks fed
on immunodeficient mice in comparison to the respective control groups of ticks fed on
immunocompetent animals (Figure 18C & D, respectively). Densitometry of the same
immunoblots show that the difference in D-dimer presence is statistically significant (P <
0.05) (Figure 18E & F). An independent experiment shown in Figure 19A-19C
corroborated this data. Immunoblotting assays performed with purified D-dimer protein
along with total lysates from ticks fed on immunocompetent mice validated that the
observed band at size ~ 200 kDa in these samples is D-dimer which was found to be
negligible in total lysates prepared from ticks fed on immunodeficient animals (Figure
18G & H, and Figure 20A & B). Densitometry was performed as a graphical
representation of the immunoblot analysis (Figure 18C and 19C). Taken together, these
results show that there is a significant decrease in fibrinogen degradation at the bite site
when ticks feed on immunodeficient animals.

Salivary Gland Lysates Prepared from Ticks Fed on Immunodeficient Animals
Show Reduced Fibrinogenolytic Activity In Vitro
Next we tested whether salivary gland lysates prepared from nymphal ticks fed
on immunodeficient animals show a decrease in fibrinogenolytic activity in vitro in
comparison to salivary gland lysates prepared from nymphs that fed on
immunocompetent animals. Immunocompetent and immunodeficient mice were infested
with nymphs. The nymphs were collected upon repletion and were processed for
salivary gland isolation. Purified fibrinogen was incubated with the salivary gland lysates
over time. The sample when subjected to PAGE showed a reduction in the degradation
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of Aα chain of fibrinogen in the presence of CaCl2 at 2 and 4 hours post-incubation vs.
the salivary gland lysates prepared from nymphs fed on immunocompetent animals
(Figure 21A & B). Densitometry was performed to graphically represent this observation
(Figure 21C & D). The salivary gland lysates prepared from nymphs fed on
immunocompetent mice showed increased degradation of Aα chain of fibrinogen in the
presence of CaCl2 even at shorter incubation times of 15 and 30 min in vs. salivary
gland lysates from nymphs fed on immunodeficient mice as shown in Figure 22. The
degradation of fibrinogen Aα chain (in all cases) was abrogated in the presence of
EDTA. Increased fibrinogenolytic activity was observed with the salivary gland lysates
prepared from ticks fed on BALB/c mice even upon exposure to EDTA (Figure 21F &
H). CaCl2 or EDTA did not result in any degradation of fibrinogen as seen in Figure 23.
The salivary gland lysates used in the fibrinogenolysis assay by themselves did not
show any prominent bands that coincided with the size of the fibrinogen (Figure 21).

The Expression of the Tested Metalloprotease Genes Did Not Show Any
Alteration in Ticks That Fed on Immunocompetent Mice vs Immunodeficient Mice
A tick metalloprotease belonging to reprolysin family containing pre- and proenzyme domains, zinc-binding motif and cysteine-rich region from salivary glands of I.
scapularis has been suggested to participate in fibrinogenolytic activities (Francischetti
et al., 2003). Therefore, we analyzed expression of four tick metalloproteases (GenBank
acc. nos. XM_002416249, XM_002416250 and XM_002412196) along with the salivary
gland metalloprotease (GenBank acc. no. AY264367) that was previously suggested to
participate in fibrinogenolysis (Francischetti et al., 2003). QRT-PCR analysis revealed
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that the expression of the tested metalloproteases did not show significant (p > 0.05)
difference in expression between ticks that were fed on immunocompetent or
immunodeficient animals (Figure 24A-D).

LC-MS/MS Based Identification of Proteins Showing Differential Expression in the
Salivary Glands of Ticks Fed on Immunocompetent vs Immunodeficient Mice
A 1-D PAGE with the salivary gland lysates prepared from ticks fed on
immunocompetent or immunodeficient animals was performed (Figure 25A). A band
showing increased intensity at ~ 100 kDa in the salivary glands of ticks fed on C57BL/6J
mice was chosen for further analysis (Figure 25A and Figure 26A & B). Similar results
were obtained for the ~ 100 kDa band in the salivary gland lysates prepared from ticks
fed on BALB/c mice in comparison to salivary gland lysates prepared from ticks fed on
SCID mice (Figure 26C and D). Since the ~ 100 kDa band was upregulated in both sets
of immunocompetent mice, this band was excised from the C57BL/6J fed tick samples
and subjected to LC-MS/MS analysis. The result revealed higher peptide matches for
tick HSP70-like proteins (Table 2, Figure 27A & B). The LC-MS/MS experimental
procedures were performed by our collaborator Dr. Sucharita Dutta.

One Isoform of the Tick HSP70-Like Molecules is Upregulated in Nymphs Fed on
Immunocompetent Animals vs Immunodeficient Animals
QRT-PCR analysis was performed with the samples generated from whole
larvae fed on C57BL/6J or RAG-/- mice for all six tick HSP70-like isoforms that were
identified in LC-MS/ MS analysis (Table 2). The mRNA levels for five of the HSP70-like
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genes (GenBank Acc. Nos. XM_002433611, XM_002407088, XM_002406516,
XM_002415881, and XM_002402518) were found to be unchanged in larvae fed on
either group of mice (Figure 25B-F). However, one of the HSP70-like molecules
(GenBank Acc. No. XM_002412155) was found to be significantly (P < 0.05)
upregulated in ticks fed on immunocompetent mice in comparison to ticks fed on
immunodeficient mice (Figure 25G). Alignment of the amino acid sequences of all
HSP70-like molecules analyzed in this study using ClustalW program revealed a high
degree of conservation across the entire sequence (Figure 28). The tick HSP70-like
molecule (XM_002412200) corresponding to the nucleotide sequence (GenBank acc.
no. XM_002412155) shares approximately 82, 47, 72, 81, 59% identity respectively with
other tick HSP70-like molecules (GenBank acc. nos. XP-002406560, XP_002402562,
XP_002407132, XP_002415926, XP_002433656) analyzed in this study (Figure 28).
Mr. Vikas Taank (graduate student with Dr. Neelakanta) performed the qRT-PCR
analysis for the HSP70- like tick genes, published in Vora et al., 2017. Taken together,
the results from LC-MS/MS and qRT-PCR analysis provide important insights on the
novel role for the participation of specific tick HSP70-like molecule in fibrinogenolysis
during blood feeding.

Treatment of Salivary Gland Lysates with VER-155008 (HSP70 inhibitor) or with
Anti-HSP70 Antibody Resulted in Reduced Fibrinogenolytic Activity
To validate whether HSP70-like molecules in ticks participate in fibrinogenolysis,
salivary gland lysates prepared from ticks fed on C57BL/6J were incubated with VER155008 or with mock (DMSO). Salivary gland lysates treated with HSP70 inhibitor
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showed reduced Aα chain degradation in comparison to the mock-treated lysates
(Figure 29A & B). Similar assays were performed with salivary gland lysates prepared
from ticks fed on C57BL/6J in the presence of anti-HSP70 antibody vs. isotype-matched
antibody (Figure 29C). Salivary gland lysates treated with anti-HSP70 antibody showed
reduced Aα chain degradation in comparison to the isotype-treated controls at 15 and
30 min incubations (Figure 29C & D). Collectively, these results support a novel role for
the participation of tick HSP70-like molecule in variable fibrinogenolysis during blood
feeding on hosts with different immune backgrounds.
A

B

Figure 17. Engorgement Weights of Ticks Increase upon Feeding on Immunodeficient Animals
(A and B) Uninfected, unfed larvae were fed on gender and age matched immunocompetent mice
(C57BL/6J, BALB/c) or immunodeficient (RAG-/-, SCID) mice. Data from C57BL/6J and RAG-/- and
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BALB/c and SCID NCr mice is shown. In both sets, the weights are greater in ticks fed on
immunodeficient mice vs. immunocompetent. Each circle represents one individual tick.
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Figure 18. Fibrin Degradation Product (D-dimer) Was Reduced in Ticks Fed on Immunodeficient
Animals
(A and B)The total protein profile from ticks fed on individual mice (3 mice/group) is shown.
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(C and D) Immunoblotting performed with larval total lysates and anti-D-dimer antibody showed negligible
or reduced D-dimer in ticks fed on immunodeficient animals vs. immunocompetent groups.
(E and F) Densitometry analysis showing presence of D-dimer in C57BL/6J, RAG-/- samples and BALB/c,
SCID samples relative to the respective bands seen in (A) and (B) (marked with asterisk).
(G) Ponceau S stained membrane image showing D-dimer along with tick total lysates.
(H) Immunoblotting assays with anti-D-dimer antibody show the presence of D-dimer in lysates prepared
from ticks fed on immunocompetent animals at the same position (~ 200 kDa) as native D-dimer protein.
Arrow next to the immunoblots (C, D & H) indicates position of D-dimer.
A
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Figure 19. Independent Experiment Showing Presence of D-Dimer in Ticks Fed on
Immunocompetent Animals
(A) 3-5 larvae fed on C57BL/6J or RAG-/- were pooled and total lysates were prepared. Total protein
profile of the two samples are shown.
(B) Immunoblotting performed with tick total lysates and anti-D-dimer antibody showed significantly
reduced level of D-dimer in ticks fed on immunodeficient animals in comparison to ticks fed on
immunocompetent animals.
(C) Densitometry for the immunoblot shown in (B). D-dimer presence was calculated relative to the
respective bands seen in (A) marked with asterisk.
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Figure 20. The Amount of D-Dimer is Reduced in Ticks Fed on Immunodeficient Animals
(A) Inverted image or,
(B) low intensity image for data in Figure 18H is shown. Immunoblotting with anti-D-dimer antibody
showed presence of D-dimer in lysates prepared from ticks fed on immunocompetent animals (C57BL/6J,
BALB/c) at the same position (~ 200 kDa) as native D-dimer protein. The arrow indicates position of Ddimer.
(C) Densitometry analysis for the immunoblot in B showing the level of D-dimer in ticks fed on
immunocompetent or immunodeficient mice. The level of D-dimer for each sample was measured relative
to the control band indicated with an asterisk in Figure 18G.
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Figure 21. Salivary Gland Lysates Prepared from Ticks Fed on Immunodeficient Animals Show
Reduced In Vitro Fibrinogenolytic Activity
(A and B) Purified fibrinogen was incubated with the salivary gland lysates for the indicated times (in
hours) in the presence of 1 mM CaCl2 where there is increased fibrinogenolysis with time in
immunocompetent samples vs. immunodeficient. Solid arrow indicates Aα chain of fibrinogen and dotted
line indicates degradation product.
(C and D) show densitometry of bands observed in (A and B).
(E and F) Reactions incubated with 1 mM EDTA do not show any fibrinogenolysis or show abrogated
fibrinogenolysis.
(G and H) show densitometry of bands observed in (E and F).
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Figure 22. Salivary Gland Lysates Prepared From Ticks Fed on Immunocompetent Animals Show
Increased Fibrinogenolytic Activity Even at Early Time Points
(A) Purified fibrinogen was incubated with tick salivary gland lysates for the indicated times (in minutes) in
the presence of 1 mM CaCl2 or,
(B) 1 mM EDTA showing similar results as Figure 21.

Figure 23. Treatment of CaCl2 or EDTA Alone Had No effect on Fibrinogen Degradation
SDS-PAGE analysis of salivary gland lysates prepared from ticks fed on immunocompetent or
immunodeficient mice showed no prominent fibrinogen degradation products. Incubation of fibrinogen
with CaCl2 or EDTA alone had no effect on fibrinogen degradation.
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Figure 24. Expression of Metalloproteases is Unaltered in Ticks upon Feeding on
Immunocompetent or Immunodeficient Animals
(A, B, C and D) QRT-PCR results showing levels of four arthropod metalloproteases, GenBank acc. nos.
AY264367 (A), XM_002416249 (B), XM-002416250 (C) and XM_002412196 (D), transcripts in ticks fed
on immunocompetent (C57BL/6J) or immunodeficient (RAG-/-) animals. The mRNA levels for
metalloproteases are normalized to tick beta-actin. Each circle represents one tick.
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Figure 25. Transcripts of Arthropod HSP70-Like Proteins are Downregulated in Immunodeficient
Animals
(A) 1-D SDS-PAGE profile in salivary glands of ticks fed on C57BL/6 J or RAG−/− mice is shown. Solid
arrow indicates around 100 kDa band (that was excised and processed by LC-MS/MS analysis) and
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dotted arrow indicates another band around 73 kDa that were found to be upregulated in salivary gland
lysates prepared from ticks fed on immunocompetent mice.
(B, C, D, E, F and G) QRT-PCR results showing levels of XM_002433611 (B), XM_002407088 (C),
XM_002406516 (D), XM_002415881 (E), XM_002402518 (F) and XM_002412155 (G) transcripts in ticks
fed on immunocompetent or immunodeficient mice.
(G) Transcript XM_00241255 was undetectable or had very low threshold levels in some of the ticks that
were fed on immunodeficient animals.
Each circle represents one tick. Student’s t test p values are shown. Mr. Vikas Taank performed the qRTPCR analysis for this figure.
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Figure 26. SDS-PAGE Analysis of Total Protein Profiles in Ticks Fed on Immunocompetent or
Immunodeficient Animals
(A and B) Densitometry analysis for the SDS-PAGE gel image from Figure 25A showing levels of ~100
kDa (A) and ~ 73 kDa (B) protein band in ticks fed on C57BL/6J or RAG-/- mice.
(C) 1-D SDS-PAGE analysis of total protein profile in salivary glands of ticks fed on BALB/c or SCID is
shown. Solid arrow indicates band around ~ 100 kDa that was upregulated in salivary gland lysates
prepared from ticks fed on BALB/c mice in comparison to salivary gland lysates prepared from ticks fed
on SCID mice.
(D) Densitometry analysis using control bands indicated using the asterisk in (C).

83
Table 2. LC-MS/MS Data Showing Presence of Arthropod HSP70-Like Proteins in Salivary Gland
Lysates Prepared from Ticks Fed on Immunocompetent Mice.
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B

Figure 27. Extracted Ion Chromatogram from LC-MS/MS Analysis
(A) The Uniprot sequence for XM_002412155 identified in the MS analysis are colored in blue or red text.
Orange triangles indicate oxidation sites and blue triangles indicate carbamidomethylation sites.
(B) Extracted Ion Chromatograms for all identified peptides for Uniprot sequence (B7Q7S0) with
GenBank acc. no. XM_002412155. Dr. Sucharita Dutta performed the LC-MS/MS analysis.
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Figure 28. Alignment of I. scapularis HSP70-Like Molecules Identified from LC-MS/MS Analysis
Amino acid sequence alignments were performed using Clustal W program in DNASTAR Lasergene.
Residues that match are shaded as black color. The GenBank accession numbers for proteins
XP_002412200, XP_002406560, XP_002402562, XP_002407132, XP_002415926 and XP_002433656
corresponds to the nucleotide accession numbers XM_002412155, XM_002406516, XM_002402518,
XM_002407088, XM_002415881 and XM_002433611, respectively. Percent identities for XP_002412200
(GenBank nucleotide acc. no. XM_002412155) in comparison to other HSP70-like molecules are shown
at the bottom of the alignment.
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C

B

D

Figure 29. Tick HSP70-Like Protein Participates in Variable Fibrinogenolysis
(A) Fibrinogenolysis assays performed with salivary gland lysates prepared from ticks fed on
immunocompetent animals in the presence of a HSP70 inhibitor or equal volume of mock control and
incubated over time. Solid arrow indicates increased Aα chain fibrinogen degradation and dotted arrow
indicates increased fibrinogen-degraded product at 30 min in mock control in comparison to inhibitortreated samples.
(B) Densitometry analysis for data shown in (A).
(C) Fibrinogenolysis performed with salivary gland lysates prepared from ticks fed on immunocompetent
animals in the presence of anti-HSP70 antibody or an isotype control and incubated over time. Arrow
indicates increased fibrinogen degradation in the presence of isotype-matched control antibody.
(D) Densitometry analysis for data shown in (C).
In (B and D), the intensity of Aα was measured relative to the intensity of Aα chain at 0 min time point.

87
DISCUSSION

Acquiring a blood meal is a multi-step process for ticks. It involves attachment to
the host, insertion of their proboscis, secretion of their saliva into the host’s dermis and
blood stream, engorgement on host blood, and detachment after repletion. To
accomplish this while evading detection and immune defense mechanisms, the ticks
produce many tick molecules (Brossard and Wikel, 2004; Francischetti et al., 2009;
Hovius et al., 2008; Ramos and Selistre-de-Araujo, 2006; Ribeiro and Francischetti,
2003; Wikel, 2013). Fibrinogenolysis at the bite site is once such evasive mechanism
elicited by ticks to achieve suppressed host coagulation. We report through this study a
novel role for arthropod HSP70-like molecules in tick-induced fibrinogenolysis. The
hypothesis is that the increase in post-engorgement weight of ticks fed on
immunodeficient mice is due to reduced fibrin/fibrinogen clotting in these mice. The
results show a lower expression of an hsp70-like molecule in ticks that fed on
immunodeficient animals with respect to the immunocompetent cohort (Figure 25A and
G). This is consistent with the reduced fibrinogen degradation around the tick bite site
on these animals (Figure 18, 19, 20, 21 and 22). The increased transcriptional
expression for only one of the HSP70-like molecule out of six molecules analyzed in this
study does not rule out involvement of the other HSP70-like molecules at different
stages of engorgement in ticks. The reduced presence of murine D-dimer in ticks fed on
immunodeficient mice in comparison to ticks fed on immunocompetent mice strongly
supports this hypothesis (Figure 18). Decreased fibrin/ fibrinogen clotting could account
for higher blood in-take and weight of ticks fed on the immunodeficient animals (Figure
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17) and possibly increased transmission of pathogens. The case for higher chance of
pathogen transmission is supported by a study that has reported an increased rate of
transmission of pathogens from ticks to immunodeficient animals in comparison to the
immunocompetent animals (Bockenstedt et al., 2006).
A previous study has shown that antibodies generated against recombinant
Haemaphysalis longicornis HSP70 recognized bands at approximately 100, 72 and 28
kDa in the egg lysates prepared from these ticks (Tian et al., 2011). This suggests that
insects like Haemaphysalis longicornis or I. scapularis may be expressing a molecule
similar to HSP70 but with a different size or that the tick HSP70-like molecules undergo
several posttranslational modifications. HSP70s also form antiparallel dimers stabilized
by post-translational modifications to position them for transfer to HSP90 (Morgner et
al., 2015). Taken together, the observation of an HSP70-like peptide sequence
recording the highest peptide match and scores in our LC-MS/MS analysis for a ~100
kDa band is not surprising.
From the works of Tytell and Hightower one can draw precedent that HSP70
could transit through the extracellular spaces (Hightower and Guidon, 1989; Tytell et al.,
1986). Human serum contains significant amounts of HSP70s suggesting this
molecules existence in extracellular spaces or as secreted proteins (Pockley et al.,
1998). This, in combination with evidence that a proteasome component Sec61p and
HSP70 are involved in the degradation of fibrinogen in the mammalian cells (Xia and
Redman, 2001) confirms our data in Figures 21, 22 and 29. These data provide the
evidence that arthropod HSP70-like molecules play a role in fibrinogenolysis during tick
blood feeding. The differential ex vivo fibrinogenolysis between salivary gland lysates
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prepared from ticks fed on SCID and RAG−/− mice could be due to the two different
genetic backgrounds (BALB/c and C57BL/6 J, respectively). They could also be due to
the leakiness in the generation of some clones of T and B cells in the SCID mice. A role
for five the other HSP70-like molecules in fibrinogenolysis cannot be excluded in ticks
during feeding on diverse vertebrate hosts (deer, rabbits, birds…etc.). Future
comparative studies on all tick HSP70-like molecules would reveal whether they have
similar or redundant function during arthropod blood meals. VER155008 is an ATPcompetitive inhibitor and arrests the N-terminal domain of HSP70 that subsequently
affects substrate binding (Schlecht et al., 2013). Figure 29 shows reduced
fibrinogenolysis upon treatment of salivary glands lysates generated from ticks fed on
immunocompetent animals with VER155008.
This data suggests that the N-terminal domain of the tick HSP70-like protein is
critical for recognition of its substrate proteins that are responsible for fibrinogen
degradation. RAG−/− mice do not produce any mature T or B-lymphocytes and this is
described as a “non-leaky” immune deficiency animal model while some SCID mice
have a “leaky” mutation which leads to the development of a few clones of T and B cells
(Bosma et al., 1988). T and B-cells play important roles in the host immune responses
against tick bites (Anguita et al., 2002). The lack of T and B cells or other metabolites in
the host blood could also account for increased blood in ticks fed on immunodeficient
animals independent of the host blood clotting factors. Several studies have now
characterized various tick salivary proteins involved in T and B cell inhibition (Anguita et
al., 2002; Gillespie et al., 2001; Kotsyfakis et al., 2006). Further investigation is required
to determine whether tick HSP70-like proteins affect activation of host T and B cells
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facilitating arthropod blood feeding. The data showing a decreased fibrinogenolysis from
salivary gland lysates prepared from ticks fed on T and B-cell deficient background host
provides important future avenues in understanding the role of these cells in blood
clotting during tick feeding. It also provides direction to discover their involvement in
coagulation pathways around the feeding cavity formed by the arthropod bites.
We further hypothesize that HSP70-like molecules secreted in tick saliva may aid
in proper folding of proteins that are involved in fibrinogenolysis at the arthropod bite
site to facilitate blood feeding. However, the contribution of arthropod HSP70 molecules
to fibrinogenolysis either directly or indirectly would not rule out other salivary activities
by these molecules important during feeding.
In summary, using I. scapularis as a model, this study provides evidence that
ticks elicit variable fibrinogenolysis upon feeding on hosts with different genetic
background and/or immune status. This study is not only important in understanding the
molecular basis of the interactions at the tick-host interface but may also potentially lead
for the development of anti-tick vaccines to interfere with the life cycle of this and
perhaps other medically important vectors.
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METHODS AND MATERIALS

Ticks and Mice
Laboratory-reared specimens of Ixodes scapularis ticks were used throughout
this study. Ticks used in this study were larvae and nymphs obtained from a
continuously maintained tick colony at the Department of Epidemiology and Public
Health, Yale University (New Haven, CT) or at the Connecticut Agricultural Experiment
Station (New Haven, CT). All animal work in this study was carried out in strict
accordance with the recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institute of Health. The protocol (#16-017) approved by the Old
Dominion University Institutional Animal Care and Use Committee (Animal Welfare
Assurance Number: A3172-01) was used in this study. Animal husbandry was provided
in accordance with criteria approved by the Association for Assessment and
Accreditation of Laboratory Animal Care Program at ODU. Acepromazine (Phoenix, St.
Joseph, Missouri) tranquilizer was administered to the animals prior to handling to
minimize anxiety and/or discomfort and all efforts were made to minimize suffering. To
generate fed larvae or nymphs, unfed ticks were allowed to feed on naïve 6-8 weeks
C57BL/6J and B6.129S7-Rag1tm1Mom/J (RAG-/-) mice (Jackson laboratories) or BALB/c
and SCID NCr (Charles River Laboratories) to repletion and were collected immediately
after drop-off for tick weight measurements and RNA extractions. At least three mice
per experimental group were used. For D-dimer immunoblotting assays, ticks that were
collected from individual mouse were used for the analysis. For salivary gland lysates
preparation, ticks were pooled from three mice and used for further analysis. Tick
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rearing was conducted in a Parameter Generation and Control incubator (Black
Mountain, North Carolina) at 23°C with 95% relative humidity and a 14/10 hour
light/dark photoperiod regiment. The IBC number for this study are 15-012 and 15-013.
Fibrinogenolysis Assays
The fibrinogen (2.5 mg/mL) purchased from Sigma (USA) was dissolved in
solution with pH 7.4 containing 50 mM HEPES and 150 mM NaCl and distributed in two
portions, one with 1 mM CaCl2 and the other with 1 mM EDTA. Five micrograms of
salivary gland extracts were pre-incubated with 1 μL of 150 mM NaCl. The samples
were incubated for 90 min. In some cases, salivary gland lysates and 150 mM NaCl
solution was incubated with mock (4 μL of 1x phosphate buffered saline that
corresponds to equal volume of HSP70-inhibitor solution) or 100 μM VER155008
(HSP70-inhibitor) or with 50 μg of isotype control or anti-HSP70 antibodies (Cell
Signaling technologies, USA). The whole mix of salivary glands with 150 mM NaCl was
then added to 15 μL of fibrinogen solutions making up a total volume of 20 μL. From 20
μL reaction mix, 3 μL was immediately taken out and considered as 0 min time point
sample. Incubation was then continued and 3 μL sample was collected at different time
points (15, 30, 120 and 240 minutes). The collected samples were stored on ice until
further use. All samples were heated at 70°C for 3 min before loading on to 4-20%
gradient stain-free SDS-PAGE gels (BioRad). 12% SDS-PAGE gels were used for
HSP70-inhibitor or antibody-blocking fibrinogenolysis assays. Images for fibrinogen
degradation were captured using Chemidoc MP Imager (BioRad).
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RNA Isolation and qRT-PCR
Total RNA from fed larvae or salivary glands from nymphs was generated using
the Aurum Total RNA mini kit (BioRad, USA) following the manufacturer’s instructions.
RNA was converted to cDNA using cDNA synthesis kit (BioRad, Hercules, USA).
Standard curve was prepared using 10-fold serial dilutions starting from 1 ng to 0.00001
ng of known quantities of hsp70-like molecules or actin fragments and qRT-PCR
reactions were performed as described (Kotsyfakis et al., 2006). The generated cDNA
was used as a template for quantifying transcripts of tick hsp70-like molecules. As an
internal control and to normalize the amount of template, I. scapularis actin transcripts
were quantified using oligonucleotides 5’ GGTATCGTGCTCGACTC3’ and 5’
CAGGGCGACGTAGCAG 3’. QRT-PCR was performed using iQ-SYBR Green
Supermix (Biorad, USA). Following are the oligonucleotide primers used in this study:
XM_002433611, 5’-GAGTTTTCAAGAATGGGCGTGT-3’ and
5’-GTGAGGCTTGCTGTTCTTGTCC-3’; XM_002407088,
5’-CGGCTGATCGGTCGTCGT-3’ and 5’ CGCTGCGAGTCGTTGAAGT 3’;
XM_002406516,
5’-GCGGAACACGGAGAACACAGT-3’ and 5’-GAACCTCTTCCGCTCTCCCT-3’;
XM_002412155, 5’-GATGACCCCAAGATTCAGCAG-3’ and
5’-GCCTCGGCTGTTTCTTTCATCT-3’; XM_002415881,
5’-GAAAGAAACGGCGGAGGCT-3’ and 5’-CGTGGGCTCGTTGATGATG-3’;
XM_002402518, 5’-GTGTAGCAGTGATGGAAGGGAAGA-3’ and
5’-CAGAGAGGGTGTTGGACGCA-3’.
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Tick Weight Measurements
Fed ticks were collected immediately after repletion, cleaned with brushes to
remove any mice hair or feces and weighed using a Cahn C-31 microbalance
(Thermoelectric Co., West Chester, PA) set to a range from 25 mg to 0.1 μg. Total body
weight measurements were obtained by directly placing each tick on a balance pan.
Data in Figure 17 shows the total tick body weights for at least 75 larvae/group.

Immunoblotting and Densitometry
Total lysates from 5-7 ticks fed on C57BL/6J or RAG-/- mice and BALB/c or SCID
NCr was prepared in modified RIPA buffer (BioExpress) supplemented with EDTA-free
protease inhibitor cocktail (Sigma, USA). Protein concentrations were determined by
BCA protein assay kit (Pierce, USA). Thirty micrograms of total lysates from each group
were loaded onto a 12% non-reducing stain-free SDS-PAGE gel (BioRad) for D-dimer
immunoblotting. In addition, D-dimer protein that was purified from human plasma was
purchased from Lee Biosolutions (MO, USA) and was used in immunoblotting assays
performed on 10% SDS-PAGE gels. The protein gels were further processed for
immunoblotting as described (Sultana et al., 2010). D-dimer antibody (Biorbyt, UK) and
Rabbit polyclonal anti-IgG HRP-conjugated antibody (Santa Cruz Biotechnology Inc.)
was used to detect D-dimer. ECL reactions were performed using Advanced
WesternBright ECL HRP substrate kit (Advansta, USA) and chemi-luminescence
reaction images were captured using Chemidoc MP Imager (BioRad). Densitometry
analysis was performed using image lab software 4 by measuring intensity of D-dimer
bands relative to the control band (equal loading control) from the stain-free image. For
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fibrinogenolysis assays, densitometry analysis was performed by measuring intensity of
the degraded product band relative to the level of fibrinogen Aα at 0 min time point.
Salivary Gland Dissection
Salivary glands and gut tissues were dissected from individual freshly fed
nymphal ticks in sterile 1X phosphate buffer saline. The tissues were then pooled in one
vial and homogenized using Kontes homogenizer and disposable pestles (VWR, USA).
Protein concentrations were determined by BCA protein assay kit (Pierce, USA). Five
micrograms of salivary gland extracts were used for fibrinogenolysis assays.

Mass Spectrometry Analysis
The tick samples were run on a 1-D gel for dual purposes of sample
concentration and sample clean-up. This gel is stained with Coomassie Blue was destained and washed with a series of three washing buffers (50 mM ammonium
bicarbonate, 50% acetonitrile and 80% acetonitrile). The bound proteins were reduced
with 1 mL of 40 mM dithiothreitol for 25 minutes at 56°C. The gels were rinsed with 1
mL of 50 mM ammonium bicarbonate buffer and the reduced proteins were alkylated
with 1 mL of 50 mM Iodoacetamide for 30 minutes at 25°C in the dark with constant
mixing. The Iodoacetamide was discarded and the gel bound proteins were digested
with 0.5 mL of trypsin (20 ng/µL; Promega, Madison, WI) in 50 mM ammonium
bicarbonate buffer at 37°C with constant mixing for 12 h. After digestion, the tryptic
fraction was collected, and the gels were washed with 50mM ammonium bicarbonate to
collect any remaining tryptic peptides. The eluent containing the tryptic peptides were
dried using a Speed-Vac apparatus (Thermo Fisher Scientific, San Jose, CA) and
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stored at 4°C prior to mass spectrometric analysis. The LC-MS/MS analysis was
performed by Dr Sucharita Dutta for our published study (Vora et al., 2017).

Peptide/Protein Acquisition by ESI-MS/MS Analysis
The dried samples were dissolved with 20 µL of 0.1% formic acid/water. 2 µL of
each sample was analyzed by LC/ESI-MS/MS using a Q-Exactive (Thermo Fisher)
mass spectrometer with an Easy NanoLC-1000 system using data dependent
acquisition with dynamic exclusion (DE = 1) settings. The data dependent acquisition
settings used were a top 12 higher energy collision induced dissociation (HCD) for the
Q-Exactive MS. The Q-Exactive mass spectrometer was used with capillary
temperature, 250°C; spray voltage, 1600V; and S-lens voltage, 55%. The automatic
gain control (AGC) target was3e6 for Full MS scans and 2e5 for MS/MS scans.
Resolving power for Q-Exactive was set at 70,000 for the full MS scan, and 17,500 for
the MS/MS scan at m/z 200. LC/ESI-MS/MS analyses was conducted using a C18
column (75 µm x 150 mm). The mobile phases for the reverse phase chromatography
were (A) 0.1% HCOOH/water and (B) 0.1% HCOOH in acetonitrile. A four-step, linear
gradient was used for the LC separation (2% to 30% B in the first 47 minutes, followed
by 80%B in the next 1 minute and holding at 80% B for 12 minutes). The LC-MS/MS
analysis was performed by Dr. Sucharita Dutta for our published study (Vora et al.,
2017).
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Peptide/Protein Identification from Tick Samples
The Sequest algorithm was used to identify peptides from the resulting MS/MS
spectra by searching against the combined tick protein database extracted from Uniprot
using the appropriate taxonomy using Proteome Discoverer (version 1.3,
ThermoScientific). Searching parameters for parent and fragment ion tolerances were
set as 20 ppm and 30 mmu for the Q Exactive MS. Other parameters used were a fixed
modification of carbamidomethylation –Cys, variable modifications of oxidation (Met).
Trypsin was set as the protease with a maximum of 2 missed cleavages. Raw files and
proteome discoverer search results for the target protein were input into the quantitative
package; Pinpoint (version 1.1, ThermoScientific). The raw file was imported into the
software which analyzed the data and determined the optimal peptide targets for the
protein of interest. The software determines the retention time window and accurate m/z
ratio for each targeted peptide and produced a mass list used directly in the acquisition
method for scheduled MS/MS. Target m/z lists were generated automatically based on
tryptic cleavage, specified modifications and retention time on the chromatogram
obtained from the gel spots. Quantitation analysis was performed in an automated
fashion using the software with a 5 ppm window for extracted ion chromatograms. The
optimized acquisition method for the targeted peptides was run in triplicate to validate
the quantitative differences observed in the samples from the discovery experiment.
Label free differential analysis was performed to compare the four sets of tick samples
after sample normalization. The LC-MS/MS analysis was performed by Dr. Sucharita
Dutta for our published study (Vora et al., 2017).
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Statistics
The statistical significance of differences observed in data sets was analyzed
using GraphPad Prism6 software and Microsoft Excel. For data to compare two means,
the non-paired Student t test was performed. p values of < 0.05 were considered
significant in all tests. Wherever necessary, statistical test and p values are reported.
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CONCLUSION

These two studies provide an insight into how vector molecules could influence
pathogen transmission in different ways. This adds to the range of the vector and
pathogen molecular repertoire that can be used upon the host to make infections easier
to transmit and establish in arthropod and vertebrate hosts. In the first study involving
the transmission of dengue virus through EVs and facilitated by Tsp29Fb, some very
important new phenomenon were observed. This study is the first to show that mosquito
cells can produce EVs. Recent studies from Dr. Sultana’s laboratory shows the
production of EVs by tick cells and that these can mediate Langat virus and West Nile
Virus infection in vitro (Zhou et al., 2018). This study is also the first to show the
presence of an entire genome of DENV2 inside EVs. The study was also able to show
the presence of RNA from another serotype, DENV3 inside EVs which together with
(Zhou et al., 2018) indicates that other flaviviruses could be exhibiting similar strategies.
In addition, the study showed the presence of dengue proteins in the EVs, indicating
that once the RNA is introduced inside naïve cells, it has some viral proteins available to
readily start replicating. Although this study is not the first in showing that EVs derived
from virus infected cells can propagate infection, the data showing flaviviral contentcarrying EVs being infectious is of special importance. It indicates that receptormediated endocytosis may not be the only way for flaviviral entry, since EVs have been
shown to directly fuse with recipient cells (Barile and Vassalli, 2017; Colombo et al.,
2014; Schorey et al., 2015; Théry et al., 2002). The identification of a mosquito ortholog
of the human exosome marker CD63 provides a useful target for the abrogation of
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dengue transmission. Inhibition of Tsp29Fb leads to the reduction in dengue load and
transmission (through EVs) which fits the first criteria of a good candidate for blocking
the transmission of VBDs (Neelakanta and Sultana, 2015).
In the second study, a novel approach in studying VBDs was undertaken. The
study was designed to see the effect of the host on the vectors rather than the other
way around as many other studies have done (Brossard and Wikel, 2004; Formaglio et
al., 2018; Hovius et al., 2008; Ribeiro et al., 2007; Wikel, 2013, 1996). While trying to
determine if the immunocompetence of hosts has an effect on the vector, the study
discovered that I. scapularis ticks have a higher engorgement weight when they feed on
immunocompromised hosts. The salivary gland extracts from the same ticks when
exposed to fibrinogen showed greater fibrinogenolysis in the immunocompetent hostfed cohort. This indicates that a vector factor was not being induced during feeding and
that it was probably involved in the disruption of the host’s coagulation machinery, which
was not being triggered due to the absence of or weak effect of that pathway in
immunocompromised hosts. Though the tested metalloproteases were not involved in
this effect, the tick HSP70-like molecule was shown to be involved in the proteolysis of
fibrinogen. Thus indicating its role in disruption of the host’s coagulation response. The
significance of this study is that since the vectors take a larger blood meal or feed for
longer, they may have a higher chance of transmitting any pathogens they may be
carrying to hosts that are already immunocompromised. To firmly place this molecule as
a good candidate for transmission blocking, further studies involving pathogens need to
be performed.
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In summary, the development of vector-borne disease prevention and cure
needs urgent attention due to its high mortality rate. Vector-borne diseases also offer
exciting avenues for infectious disease research through the sheer number of
interactions and players that are involved at the vector-host-pathogen interface.
Strategies for establishing safe, effective and cheap transmission blocking vaccines
remain under investigation.
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